None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and adjacent lymph nodes , and then
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Boost-START> boost <Boost-END> to
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and a 2 cm margin if the small bowel
DOSE-BOOST	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
DOSE-BOOST	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) <Boost-START> boost <Boost-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
DOSE-BOOST	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with <Boost-START> boost <Boost-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
DOSE-BOOST	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) <Boost-START> boost <Boost-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with <Boost-START> boost <Boost-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with <Boost-START> boost <Boost-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	5.4 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with <Boost-START> boost <Boost-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Boost-START> boost <Boost-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with <Boost-START> boost <Boost-END> depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	) <Boost-START> boost <Boost-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with <Boost-START> boost <Boost-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with <Boost-START> boost <Boost-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	Gy for 25 fractions ( 45 Gy ) , with <Boost-START> boost <Boost-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Boost-START> boost <Boost-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions <Boost-START> boost <Boost-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
DOSE-BOOST	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions <Boost-START> boost <Boost-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Boost-START> boost <Boost-END> to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Boost-START> boost <Boost-END> to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Boost-START> boost <Boost-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Boost-START> boost <Boost-END> dose of 11 to 16 Gy to close (& lt
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Boost-START> boost <Boost-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Boost-START> boost <Boost-END> dose of 11 to 16 Gy to close (& lt ; 5 mm
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Boost-START> boost <Boost-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Boost-START> boost <Boost-END> dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
DOSE-BOOST	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Boost-START> boost <Boost-END> dose of 11 to <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A <Boost-START> boost <Boost-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Boost-START> boost <Boost-END> dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A <Boost-START> boost <Boost-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Boost-START> boost <Boost-END> dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
DOSE-BOOST	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A <Boost-START> boost <Boost-END> of 11 to <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A <Boost-START> boost <Boost-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of ( overall dose to these sites : 65 to 70 Gy ) . A <Boost-START> boost <Boost-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	65 to 70 Gy ) . A <Boost-START> boost <Boost-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	) . A <Boost-START> boost <Boost-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Boost-START> boost <Boost-END> of
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Boost-START> boost <Boost-END> of 172 cGy ( rads ) fractions x 10 fractions ,
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Boost-START> boost <Boost-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Boost-START> boost <Boost-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down <Boost-START> boost <Boost-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
DOSE-BOOST	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Boost-START> boost <Boost-END> of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
DOSE-BOOST	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Boost-START> boost <Boost-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Boost-START> boost <Boost-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Boost-START> boost <Boost-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	( 4300 rads ) , then coned-down <Boost-START> boost <Boost-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	coned-down <Boost-START> boost <Boost-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy +
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed
DOSE-BOOST	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
DOSE-BOOST	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
DOSE-BOOST	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	Gy <Boost-START> boost <Boost-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	the tumor bed 50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	50 Gy + 20 Gy <Boost-START> boost <Boost-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
DOSE-BOOST	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to 70 Gy
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
DOSE-BOOST	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
DOSE-BOOST	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy <Boost-START> boost <Boost-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
DOSE-BOOST	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	18 Gy <Boost-START> boost <Boost-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
DOSE-BOOST	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	to 46 Gy to the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	the pelvis , then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	then an additional <Boost-START> boost <Boost-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of <RT_Dosage-START> 81 Gy <RT_Dosage-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_Dosage-START> 30 to 35 Gy <RT_Dosage-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_Dosage-START> 75 Gy <RT_Dosage-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4
None	of <RT_Dosage-START> 40 Gy <RT_Dosage-END> to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with <RT_Dosage-START> 30 to 35 Gy <RT_Dosage-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_Dosage-START> 75 Gy <RT_Dosage-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4
None	of <RT_Dosage-START> 40 Gy <RT_Dosage-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_Dosage-START> 81 Gy <RT_Dosage-END> to point A with cesium-137 , with 30 to <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of <RT_Dosage-START> 75 Gy <RT_Dosage-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> total
None	of <RT_Dosage-START> 40 Gy <RT_Dosage-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_Dosage-START> 81 Gy <RT_Dosage-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_Dosage-START> 30 to 35 Gy <RT_Dosage-END> delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of <RT_Dosage-START> 75 Gy <RT_Dosage-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4
None	of <RT_Dosage-START> 40 Gy <RT_Dosage-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_Dosage-START> 81 Gy <RT_Dosage-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_Dosage-START> 30 to 35 Gy <RT_Dosage-END> delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4
None	of <RT_Dosage-START> 40 Gy <RT_Dosage-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_Dosage-START> 81 Gy <RT_Dosage-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_Dosage-START> 30 to 35 Gy <RT_Dosage-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_Dosage-START> 75 Gy <RT_Dosage-END> <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
DOSE-DOSE	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4
None	to 2 fractions for a total dose of <RT_Dosage-START> 81 Gy <RT_Dosage-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_Dosage-START> 30 to 35 Gy <RT_Dosage-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_Dosage-START> 75 Gy <RT_Dosage-END> 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
DOSE-DOSE	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> total ) boost to the tumor bed and
None	total dose of <RT_Dosage-START> 81 Gy <RT_Dosage-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with <RT_Dosage-START> 30 to 35 Gy <RT_Dosage-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_Dosage-START> 75 Gy <RT_Dosage-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> total ) boost to the tumor bed and adjacent lymph nodes , and then
None	35 Gy delivered to point A <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_Dosage-START> 75 Gy <RT_Dosage-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
DOSE-DOSE	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_Dosage-START> 3.6 Gy <RT_Dosage-END> total ) boost to
None	A for a total dose of <RT_Dosage-START> 75 Gy <RT_Dosage-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
DOSE-DOSE	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_Dosage-START> 3.6 Gy <RT_Dosage-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
DOSE-DOSE	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_Dosage-START> 3.6 Gy <RT_Dosage-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> for
None	fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
DOSE-DOSE	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_Dosage-START> 3.6 Gy <RT_Dosage-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_Dosage-START> 45 Gy <RT_Dosage-END> )
None	Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
DOSE-DOSE	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( <RT_Dosage-START> 3.6 Gy <RT_Dosage-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions given 5 days per week
None	bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_Dosage-START> 45 Gy , <RT_Dosage-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
DOSE-DOSE	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions given 5 days per week , for a total dose of
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_Dosage-START> 3.6 Gy <RT_Dosage-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
DOSE-DOSE	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 172 cGy <RT_Dosage-END>
None	<RT_Dosage-START> 5.4 Gy <RT_Dosage-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_Dosage-START> 3.6 Gy <RT_Dosage-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
DOSE-DOSE	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25
None	adjacent lymph nodes , and then optionally a <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_Dosage-START> 3.6 Gy <RT_Dosage-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
DOSE-DOSE	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
DOSE-DOSE	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads )
None	and a 2 cm margin if the small bowel could be avoided <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given
None	Gy for 25 fractions ( <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
DOSE-DOSE	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and
None	28 fractions given 5 days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
None	28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
DOSE-DOSE	28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
None	28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
None	28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
None	28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) 1.8 Gy fractions x 28 fractions , total
None	dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1
None	dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1
None	dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1
None	dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1
DOSE-DOSE	dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1
None	dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1
None	tumor bed . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9
None	tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9
DOSE-DOSE	tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9
None	tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9
None	fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4
DOSE-DOSE	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~
None	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~
None	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~
None	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~
None	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.7 Gy fractions x ~
None	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> fractions x ~
DOSE-DOSE	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5
None	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the tumor bed ( total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
DOSE-DOSE	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 59.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
DOSE-DOSE	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_Dosage-START> 11 to 16 Gy <RT_Dosage-END> to close (& lt
None	Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
DOSE-DOSE	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_Dosage-START> 11 to 16 Gy <RT_Dosage-END> to close (& lt ; 5 mm
None	total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
DOSE-DOSE	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_Dosage-START> 11 to 16 Gy <RT_Dosage-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	for a total dose of 50.4 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_Dosage-START> 11 to 20 Gy <RT_Dosage-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_Dosage-START> 65 to 74 Gy <RT_Dosage-END> ) ;
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_Dosage-START> 11 to 16 Gy <RT_Dosage-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of <RT_Dosage-START> 11 to 20 Gy <RT_Dosage-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_Dosage-START> 65 to 74 Gy <RT_Dosage-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 1.8
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_Dosage-START> 11 to 16 Gy <RT_Dosage-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> ) . A boost of 11 to <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : <RT_Dosage-START> 65 to 74 Gy <RT_Dosage-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions for a total of 45 Gy
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_Dosage-START> 45 Gy <RT_Dosage-END>
None	of <RT_Dosage-START> 11 to 16 Gy <RT_Dosage-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_Dosage-START> 11 to 20 Gy <RT_Dosage-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 10 fractions to the
None	of ( overall dose to these sites : <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_Dosage-START> 11 to 20 Gy <RT_Dosage-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_Dosage-START> 65 to 74 Gy <RT_Dosage-END> ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
DOSE-DOSE	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	<RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of <RT_Dosage-START> 11 to 20 Gy <RT_Dosage-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_Dosage-START> 65 to 74 Gy <RT_Dosage-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
DOSE-DOSE	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_Dosage-START> 50.0 Gy <RT_Dosage-END> 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions
None	) . A boost of <RT_Dosage-START> 11 to 20 Gy <RT_Dosage-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_Dosage-START> 65 to 74 Gy <RT_Dosage-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
DOSE-DOSE	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_Dosage-START> 50.0 Gy <RT_Dosage-END> 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions ( total dose :
None	Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_Dosage-START> 65 to 74 Gy <RT_Dosage-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
DOSE-DOSE	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_Dosage-START> 50.0 Gy <RT_Dosage-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_Dosage-START> 60 Gy <RT_Dosage-END> ) , given 5 times per week
None	to metastatic nodal sites ( overall dose to these sites : <RT_Dosage-START> 65 to 74 Gy <RT_Dosage-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_Dosage-START> 50.0 Gy <RT_Dosage-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_Dosage-START> 60 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 2
None	these sites : <RT_Dosage-START> 65 to 74 Gy <RT_Dosage-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_Dosage-START> 50.0 Gy <RT_Dosage-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_Dosage-START> 60 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	x 25 fractions ( total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : <RT_Dosage-START> 60 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 4 Gy <RT_Dosage-END> fractions once per
None	( total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_Dosage-START> 50.0 Gy <RT_Dosage-END> <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
DOSE-DOSE	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : <RT_Dosage-START> 60 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 4 Gy <RT_Dosage-END> fractions once per day x 5
None	25 fractions for a total of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_Dosage-START> 50.0 Gy <RT_Dosage-END> 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
DOSE-DOSE	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 4 Gy <RT_Dosage-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) 2
None	to the initial tumor length plus a 5 cm margin , for a total dose of <RT_Dosage-START> 50.0 Gy <RT_Dosage-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_Dosage-START> 60 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
DOSE-DOSE	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 4 Gy <RT_Dosage-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x
None	for a total dose of <RT_Dosage-START> 50.0 Gy <RT_Dosage-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_Dosage-START> 60 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
DOSE-DOSE	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> <RT_Dosage-START> 4 Gy <RT_Dosage-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	dose of <RT_Dosage-START> 50.0 Gy <RT_Dosage-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_Dosage-START> 60 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
DOSE-DOSE	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose : <RT_Dosage-START> 60 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
DOSE-DOSE	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 4 Gy <RT_Dosage-END> fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions (
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 4 Gy <RT_Dosage-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
DOSE-DOSE	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions ( target dose of 30
None	, 3 , 5 , 6 , 8 , 9 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 4 Gy <RT_Dosage-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
DOSE-DOSE	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions ,
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 4 Gy <RT_Dosage-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
DOSE-DOSE	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> total of
None	day x 5 fractions ( total dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	day x 5 fractions ( total dose : 20 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
DOSE-DOSE	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_Dosage-START> 54 Gy <RT_Dosage-END> given . Dose per fraction and total duration of treatment were not specified , but based on
None	( total dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	( total dose : 20 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
DOSE-DOSE	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_Dosage-START> 54 Gy <RT_Dosage-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
DOSE-DOSE	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_Dosage-START> 54 Gy <RT_Dosage-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 30 fractions
None	( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
None	( total dose : 70 Gy ) , given 5 days per week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
None	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
None	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
None	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
DOSE-DOSE	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
None	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_Dosage-START> 54 Gy <RT_Dosage-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
None	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 30 fractions or 2 Gy x
None	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_Dosage-START> 2 Gy <RT_Dosage-END> x
None	week <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
DOSE-DOSE	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of <RT_Dosage-START> 54 Gy <RT_Dosage-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 27 fractions . 3 Gy fractions twice per day , with
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions twice per day , with
None	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
None	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
None	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
None	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
None	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
DOSE-DOSE	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
DOSE-DOSE	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
None	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions twice per day , with the first fraction of each
None	dose of <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 ,
None	dose of 30 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 ,
None	dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 ,
DOSE-DOSE	dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_Dosage-START> 54 Gy <RT_Dosage-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 ,
DOSE-DOSE	dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 30 fractions or <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 ,
None	dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 30 fractions or 2 Gy x 27 fractions . <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 ,
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction
None	1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction
DOSE-DOSE	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_Dosage-START> 54 Gy <RT_Dosage-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction
DOSE-DOSE	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 30 fractions or <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 27 fractions . <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction
None	for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered
None	for a total dose of 50.4 Gy total of <RT_Dosage-START> 54 Gy <RT_Dosage-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered
None	for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 30 fractions or 2 Gy x 27 fractions . <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered
None	for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 27 fractions . <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered
DOSE-DOSE	for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) , administered
DOSE-DOSE	. <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
None	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
None	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
None	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
None	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 25 fractions , for
None	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 25 fractions , for
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
DOSE-DOSE	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 30 fractions , for an initial dose of 51 Gy
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END>
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
DOSE-DOSE	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END> 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_Dosage-START> 1.1 Gy <RT_Dosage-END> fractions x 70 fractions , given twice
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
DOSE-DOSE	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_Dosage-START> 1.1 Gy <RT_Dosage-END> fractions x 70 fractions , given twice per day , 5
None	, 15 , 17 ( total induction dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
DOSE-DOSE	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_Dosage-START> 1.1 Gy <RT_Dosage-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END>
None	( total induction dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_Dosage-START> 1.1 Gy <RT_Dosage-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END> ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END>
None	bladder tumor volume , and pelvic lymph nodes . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
DOSE-DOSE	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy <RT_Dosage-START> 1.1 Gy <RT_Dosage-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 1.8
None	Gy fractions x 25 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
DOSE-DOSE	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> <RT_Dosage-START> 1.1 Gy <RT_Dosage-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase
None	25 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END> <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
DOSE-DOSE	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END>
None	Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
DOSE-DOSE	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_Dosage-START> 1.1 Gy <RT_Dosage-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ,
None	Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_Dosage-START> 1.1 Gy <RT_Dosage-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
DOSE-DOSE	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose
None	Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_Dosage-START> 1.1 Gy <RT_Dosage-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END> ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
DOSE-DOSE	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an
None	x 30 fractions , for an initial dose of <RT_Dosage-START> 51 Gy <RT_Dosage-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy <RT_Dosage-START> 1.1 Gy <RT_Dosage-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
DOSE-DOSE	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an initial dose of 40.8
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
DOSE-DOSE	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of
None	times per week ( total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x
None	total dose : <RT_Dosage-START> 77 Gy <RT_Dosage-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
DOSE-DOSE	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total
None	5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
DOSE-DOSE	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2
None	week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
DOSE-DOSE	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_Dosage-START> 1.80 Gy <RT_Dosage-END>
None	fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
DOSE-DOSE	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> )
None	fractions ( total dose in consolidation phase : <RT_Dosage-START> 25.2 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
DOSE-DOSE	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2.66 Gy <RT_Dosage-END>
None	total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
DOSE-DOSE	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2.66 Gy <RT_Dosage-END> fractions once per day x 15 fractions over 3 weeks ,
None	: <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
DOSE-DOSE	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2.66 Gy <RT_Dosage-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	, for an initial dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
DOSE-DOSE	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2.66 Gy <RT_Dosage-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 39.9 Gy <RT_Dosage-END> ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given
None	Gy x 24 fractions , for an initial dose of <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
DOSE-DOSE	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2.66 Gy <RT_Dosage-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 39.9 Gy <RT_Dosage-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( at least 4 , but preferably
None	<RT_Dosage-START> 40.8 Gy <RT_Dosage-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
DOSE-DOSE	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2.66 Gy <RT_Dosage-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 39.9 Gy <RT_Dosage-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	Gy per fraction x 25 fractions , total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
None	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
None	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
None	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
None	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
DOSE-DOSE	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 39.9 Gy <RT_Dosage-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
None	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
None	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END>
None	fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
None	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
None	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
DOSE-DOSE	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2.66 Gy <RT_Dosage-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
None	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
None	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
None	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> fractions x 30 to 33
None	: <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
None	: 70 Gy ) during cycles 1 and 2 , <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
None	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
None	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2.66 Gy <RT_Dosage-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
None	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 39.9 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
DOSE-DOSE	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
None	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> fractions x 30 to 33 fractions ( total dose
None	Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 39.9 Gy <RT_Dosage-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions (
DOSE-DOSE	Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions (
None	Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions (
None	Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions (
None	Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions (
None	of chemotherapy ( total dose : <RT_Dosage-START> 39.9 Gy <RT_Dosage-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
None	of chemotherapy ( total dose : 39.9 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
None	of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
DOSE-DOSE	of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x 30 to 33 fractions ( total dose : <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
None	of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
None	of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
None	twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45
DOSE-DOSE	twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> fractions x 30 to 33 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45
None	twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45
None	twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45
None	twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45
None	4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7
None	4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7
None	4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7
DOSE-DOSE	4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7
None	4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7
None	4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.7
None	, started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
None	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
DOSE-DOSE	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
None	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
None	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
None	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
None	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_Dosage-START> 49.3 Gy <RT_Dosage-END> , starting on cycle 1 day 1 1.8 Gy
None	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END>
None	30 to 33 fractions ( total dose : <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
DOSE-DOSE	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_Dosage-START> 49.3 Gy <RT_Dosage-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 172 cGy (
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 172 cGy <RT_Dosage-END> (
None	) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
None	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
DOSE-DOSE	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
None	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
None	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of <RT_Dosage-START> 49.3 Gy <RT_Dosage-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
None	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
None	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
None	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for
None	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
None	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
None	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
DOSE-DOSE	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of <RT_Dosage-START> 49.3 Gy <RT_Dosage-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
None	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
None	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
None	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
None	fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
DOSE-DOSE	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_Dosage-START> 49.3 Gy <RT_Dosage-END> , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
DOSE-DOSE	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions ,
None	2 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_Dosage-START> 49.3 Gy <RT_Dosage-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
DOSE-DOSE	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> (
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_Dosage-START> 1.7 Gy <RT_Dosage-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_Dosage-START> 49.3 Gy <RT_Dosage-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
DOSE-DOSE	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and
None	29 fractions , for a total dose of <RT_Dosage-START> 49.3 Gy <RT_Dosage-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
DOSE-DOSE	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) 200 cGy fractions x 4 doses ( 8
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions x 4 doses ( 8
None	starting on cycle 1 day 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
None	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
None	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
None	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
DOSE-DOSE	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
None	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
None	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
None	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_Dosage-START> 8 Gy <RT_Dosage-END> total ) in 2 Gy fractions once per day
None	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day
None	<RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	50.4 Gy ) <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
DOSE-DOSE	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_Dosage-START> 8 Gy <RT_Dosage-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 850 to 1020 cGy in
None	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 850 to 1020 cGy <RT_Dosage-END> in
None	fractions , given over 5 weeks for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( <RT_Dosage-START> 8 Gy <RT_Dosage-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 850 to 1020 cGy <RT_Dosage-END> in 5 to 6 fractions delivered on days - 3 to - 1
None	for a total dose of <RT_Dosage-START> 4300 cGy <RT_Dosage-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
DOSE-DOSE	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( <RT_Dosage-START> 8 Gy <RT_Dosage-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 850 to 1020 cGy <RT_Dosage-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28
None	( 4300 rads ) , then coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
DOSE-DOSE	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 850 to 1020 cGy <RT_Dosage-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose 2 Gy
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_Dosage-START> 2 Gy <RT_Dosage-END>
None	coned-down boost of <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_Dosage-START> 8 Gy <RT_Dosage-END> total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
DOSE-DOSE	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 850 to 1020 cGy <RT_Dosage-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions ( total
None	, given over 2 weeks for a dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_Dosage-START> 8 Gy <RT_Dosage-END> total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
DOSE-DOSE	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding <RT_Dosage-START> 850 to 1020 cGy <RT_Dosage-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_Dosage-START> 3.40 Gy <RT_Dosage-END> fractions , five days per week
None	dose of <RT_Dosage-START> 1720 cGy <RT_Dosage-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_Dosage-START> 8 Gy <RT_Dosage-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 850 to <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_Dosage-START> 3.40 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 34 Gy <RT_Dosage-END>
None	) <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( <RT_Dosage-START> 8 Gy <RT_Dosage-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 850 to 1020 cGy <RT_Dosage-END> in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_Dosage-START> 3.40 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 34 Gy <RT_Dosage-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_Dosage-START> 2.33 Gy <RT_Dosage-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_Dosage-START> 35 Gy <RT_Dosage-END> 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_Dosage-START> 5.0 Gy <RT_Dosage-END>
None	Gy total ) in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 850 to 1020 cGy <RT_Dosage-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x <RT_Dosage-START> 3.40 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 34 Gy <RT_Dosage-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_Dosage-START> 2.33 Gy <RT_Dosage-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_Dosage-START> 35 Gy <RT_Dosage-END> 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_Dosage-START> 5.0 Gy <RT_Dosage-END> once per day for a total of 5 fractions (
None	4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 850 to 1020 cGy <RT_Dosage-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
DOSE-DOSE	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of <RT_Dosage-START> 34 Gy <RT_Dosage-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy <RT_Dosage-START> 2.33 Gy <RT_Dosage-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_Dosage-START> 35 Gy <RT_Dosage-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_Dosage-START> 5.0 Gy <RT_Dosage-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
DOSE-DOSE	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_Dosage-START> 3.40 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> <RT_Dosage-START> 2.33 Gy <RT_Dosage-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of <RT_Dosage-START> 35 Gy <RT_Dosage-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_Dosage-START> 5.0 Gy <RT_Dosage-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) . See Chan et al
None	5 to 6 fractions delivered on days - 3 to - 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_Dosage-START> 3.40 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 34 Gy <RT_Dosage-END> <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
DOSE-DOSE	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of <RT_Dosage-START> 35 Gy <RT_Dosage-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy <RT_Dosage-START> 5.0 Gy <RT_Dosage-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) . See Chan et al . 2005
None	1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_Dosage-START> 3.40 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 34 Gy <RT_Dosage-END> 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
DOSE-DOSE	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_Dosage-START> 2.33 Gy <RT_Dosage-END> fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> <RT_Dosage-START> 5.0 Gy <RT_Dosage-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions
None	Gy fractions x 28 fractions ( total dose <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_Dosage-START> 3.40 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 34 Gy <RT_Dosage-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_Dosage-START> 2.33 Gy <RT_Dosage-END> fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_Dosage-START> 35 Gy <RT_Dosage-END> <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
DOSE-DOSE	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions
None	( total dose 10 x <RT_Dosage-START> 3.40 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 34 Gy <RT_Dosage-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_Dosage-START> 2.33 Gy <RT_Dosage-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_Dosage-START> 35 Gy <RT_Dosage-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
DOSE-DOSE	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_Dosage-START> 5.0 Gy <RT_Dosage-END> once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	10 x <RT_Dosage-START> 3.40 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 34 Gy <RT_Dosage-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_Dosage-START> 2.33 Gy <RT_Dosage-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_Dosage-START> 35 Gy <RT_Dosage-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_Dosage-START> 5.0 Gy <RT_Dosage-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
DOSE-DOSE	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2
None	, for a total dose of <RT_Dosage-START> 34 Gy <RT_Dosage-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
None	, for a total dose of 34 Gy <RT_Dosage-START> 2.33 Gy <RT_Dosage-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
None	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_Dosage-START> 35 Gy <RT_Dosage-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
None	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_Dosage-START> 5.0 Gy <RT_Dosage-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
None	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
DOSE-DOSE	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
None	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
None	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2 Gy fractions x 27 fractions ( total dose : 54
None	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 27 fractions ( total dose : 54
None	<RT_Dosage-START> 35 Gy <RT_Dosage-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	35 Gy <RT_Dosage-START> 5.0 Gy <RT_Dosage-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
DOSE-DOSE	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
None	) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
DOSE-DOSE	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 6 fractions ( boost dose : 12 Gy )
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_Dosage-START> 12 Gy ) <RT_Dosage-END>
None	fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
DOSE-DOSE	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_Dosage-START> 12 Gy ) <RT_Dosage-END> 1.5 Gy fractions given
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given
None	) . See Chan et al . 2005 for additional information about boost doses . <RT_Dosage-START> 2.10 Gy <RT_Dosage-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
DOSE-DOSE	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_Dosage-START> 12 Gy ) <RT_Dosage-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day x 16 fractions ( total dose :
None	, given during cycle 1 of chemotherapy ( total dose : <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
DOSE-DOSE	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : <RT_Dosage-START> 12 Gy ) <RT_Dosage-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions (
None	: <RT_Dosage-START> 52.5 Gy <RT_Dosage-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
DOSE-DOSE	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 6 fractions ( boost dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END>
None	<RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : <RT_Dosage-START> 54 Gy <RT_Dosage-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_Dosage-START> 12 Gy ) <RT_Dosage-END> <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
DOSE-DOSE	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_Dosage-START> 12 Gy ) <RT_Dosage-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
DOSE-DOSE	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_Dosage-START> 12 Gy ) <RT_Dosage-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
DOSE-DOSE	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose :
None	dissemination or that had inadequate resection margins of <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_Dosage-START> 12 Gy ) <RT_Dosage-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
DOSE-DOSE	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END>
None	had inadequate resection margins of <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_Dosage-START> 12 Gy ) <RT_Dosage-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
DOSE-DOSE	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20
None	( boost dose : <RT_Dosage-START> 12 Gy ) <RT_Dosage-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
DOSE-DOSE	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x
None	) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
DOSE-DOSE	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total
None	x 16 fractions ( total dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
DOSE-DOSE	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) , given 5 times
None	total dose : <RT_Dosage-START> 24 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
DOSE-DOSE	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) , given 5 times per week 2
None	x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
DOSE-DOSE	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 to 37 fractions ( total dose
None	Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
DOSE-DOSE	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) , given 5 times
None	total dose of <RT_Dosage-START> 68 to 70 Gy <RT_Dosage-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
DOSE-DOSE	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_Dosage-START> 1.8 Gy <RT_Dosage-END>
None	to 70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
DOSE-DOSE	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions ,
None	( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
DOSE-DOSE	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , starting on
None	fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
DOSE-DOSE	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions
None	given 6 times per week <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
DOSE-DOSE	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 to 37 fractions ( total dose : 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions (
None	Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
DOSE-DOSE	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 39.6 Gy <RT_Dosage-END> ; total overall dose in induction and
None	dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	dose : 66 Gy ) , given 5 times per week <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
DOSE-DOSE	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 39.6 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 2 Gy fractions x
None	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x
None	<RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 39.6 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x
None	dose : <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
DOSE-DOSE	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 39.6 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for
None	over 7 to 7.5 weeks <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
DOSE-DOSE	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions
None	for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 39.6 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per
None	of <RT_Dosage-START> 45 Gy <RT_Dosage-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 39.6 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
DOSE-DOSE	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions
None	or 1 <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 39.6 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
DOSE-DOSE	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions
None	x 18 fractions ( total dose <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_Dosage-START> 39.6 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
DOSE-DOSE	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a
None	total dose in consolidation phase : <RT_Dosage-START> 39.6 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
DOSE-DOSE	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then
None	consolidation phase : <RT_Dosage-START> 39.6 Gy <RT_Dosage-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
DOSE-DOSE	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions
None	consolidation phases : <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
DOSE-DOSE	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total
None	<RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
DOSE-DOSE	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total dose : 70.2
None	total dose : <RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
DOSE-DOSE	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_Dosage-START> 70.2 Gy <RT_Dosage-END> ) , given 5 times per week 15 x
None	<RT_Dosage-START> 64 Gy <RT_Dosage-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
DOSE-DOSE	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_Dosage-START> 70.2 Gy <RT_Dosage-END> ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions
None	per week , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
DOSE-DOSE	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_Dosage-START> 70.2 Gy <RT_Dosage-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 40.05
None	for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_Dosage-START> 70.2 Gy <RT_Dosage-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8
None	<RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_Dosage-START> 70.2 Gy <RT_Dosage-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , starting within
None	for a total dose of <RT_Dosage-START> 46 Gy <RT_Dosage-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
DOSE-DOSE	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : <RT_Dosage-START> 70.2 Gy <RT_Dosage-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , starting within 24 hours of the first dose of
None	per fraction x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
DOSE-DOSE	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> .
None	<RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_Dosage-START> 70.2 Gy <RT_Dosage-END> ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
DOSE-DOSE	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total of
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_Dosage-START> 70.2 Gy <RT_Dosage-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
DOSE-DOSE	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.50 Gy fractions given twice per day x 30 fractions over
None	fractions x 25 fractions , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_Dosage-START> 70.2 Gy <RT_Dosage-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
DOSE-DOSE	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	<RT_Dosage-START> 70.2 Gy <RT_Dosage-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
None	70.2 Gy ) , given 5 times per week 15 x <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
None	70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
DOSE-DOSE	70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
None	70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
None	70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
None	70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( at
None	given 5 times per week 15 x <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but
None	given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but
None	given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but
None	given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but
DOSE-DOSE	given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but
None	given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( at least 4 , but
None	, five days per week , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	, five days per week , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	, five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.8 Gy fractions x 28 fractions , for a total of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
DOSE-DOSE	, five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	, five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	, for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks . Skarlos et al . 2001 examined two different timings for radiation therapy . There was no significant difference between
None	, for a total dose of 45 Gy . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks . Skarlos et al . 2001 examined two different timings for radiation therapy . There was no significant difference between
None	, for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks . Skarlos et al . 2001 examined two different timings for radiation therapy . There was no significant difference between
DOSE-DOSE	, for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) over 3 weeks . Skarlos et al . 2001 examined two different timings for radiation therapy . There was no significant difference between
DOSE-DOSE	fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks . Skarlos et al . 2001 examined two different timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1
DOSE-DOSE	timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions x 15 fractions , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose :
None	timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions x 15 fractions , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose :
None	timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose :
None	timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose :
None	timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 2.0 Gy fractions given 5 times per week ( total dose :
None	timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose :
DOSE-DOSE	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an
DOSE-DOSE	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
DOSE-DOSE	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> ,
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
DOSE-DOSE	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8
None	; late HTRT is given during cycle 4 of chemotherapy . <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
DOSE-DOSE	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END>
None	is given during cycle 4 of chemotherapy . <RT_Dosage-START> 2.67 Gy <RT_Dosage-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
DOSE-DOSE	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36
None	x 15 fractions , for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
DOSE-DOSE	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed
None	for a total dose of <RT_Dosage-START> 40.05 Gy <RT_Dosage-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
DOSE-DOSE	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> +
None	dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
DOSE-DOSE	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33
None	30 fractions , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-DOSE	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
DOSE-DOSE	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9
None	fractions given 5 times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
DOSE-DOSE	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the
None	times per week ( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
DOSE-DOSE	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed
None	( total dose : <RT_Dosage-START> 66-70 Gy <RT_Dosage-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END>
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to
None	x 20 to 22 fractions , for an initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed
None	initial total dose of <RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x
None	<RT_Dosage-START> 36 to 39.6 Gy <RT_Dosage-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
DOSE-DOSE	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then
None	<RT_Dosage-START> 1.80 Gy <RT_Dosage-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
DOSE-DOSE	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions
None	, total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
DOSE-DOSE	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END>
None	of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
DOSE-DOSE	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction
None	to <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial
None	Gy boost to the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
DOSE-DOSE	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then
None	the tumor bed <RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
DOSE-DOSE	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then an additional
None	<RT_Dosage-START> 50 Gy <RT_Dosage-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + <RT_Dosage-START> 20 Gy <RT_Dosage-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then an additional boost to the prostate
None	total dose minimum of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
DOSE-DOSE	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	of <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
DOSE-DOSE	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END>
None	x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
DOSE-DOSE	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> in definitive radiation patients ; 60 to 65
None	total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
DOSE-DOSE	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_Dosage-START> 60 to 65 Gy <RT_Dosage-END> total dose for
None	to <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 9 Gy <RT_Dosage-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
DOSE-DOSE	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_Dosage-START> 60 to 65 Gy <RT_Dosage-END> total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) ,
None	to the tumor bed to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
DOSE-DOSE	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_Dosage-START> 60 to 65 Gy <RT_Dosage-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> )
None	in <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then <RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
DOSE-DOSE	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; <RT_Dosage-START> 60 to 65 Gy <RT_Dosage-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_Dosage-START> 36 Gy <RT_Dosage-END>
None	<RT_Dosage-START> 18 Gy <RT_Dosage-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
DOSE-DOSE	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily
None	<RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial <RT_Dosage-START> 44 to 46 Gy <RT_Dosage-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_Dosage-START> 60 to 65 Gy <RT_Dosage-END> total dose for post-prostatectomy patients 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_Dosage-START> 60 to 65 Gy <RT_Dosage-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> per target bone lesion for up
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_Dosage-START> 60 to 65 Gy <RT_Dosage-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
DOSE-DOSE	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> per target bone lesion for up to three bone lesions
None	then an additional boost to the prostate that resulted in a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_Dosage-START> 60 to 65 Gy <RT_Dosage-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
DOSE-DOSE	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_Dosage-START> 36 Gy <RT_Dosage-END> in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> per target bone lesion for up to three bone lesions per patient ,
None	a total dose of <RT_Dosage-START> 65 to 70 Gy <RT_Dosage-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_Dosage-START> 60 to 65 Gy <RT_Dosage-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	Gy in definitive radiation patients ; <RT_Dosage-START> 60 to 65 Gy <RT_Dosage-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END>
None	to 65 Gy total dose for post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_Dosage-START> 10 to 12 Gy <RT_Dosage-END> total
None	post-prostatectomy patients <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_Dosage-START> 10 to 12 Gy <RT_Dosage-END> total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_Dosage-START> 1200 cGy <RT_Dosage-END> in fractions (
None	5 days per week <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_Dosage-START> 10 to 12 Gy <RT_Dosage-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_Dosage-START> 1200 cGy <RT_Dosage-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	Gy in 15 daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> <RT_Dosage-START> 10 to 12 Gy <RT_Dosage-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total <RT_Dosage-START> 1200 cGy <RT_Dosage-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_Dosage-START> 45 to 50.4 Gy <RT_Dosage-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> given in 25 fractions with cycles 3 and 4
None	daily fractions <RT_Dosage-START> 36 Gy <RT_Dosage-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 10 to <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total <RT_Dosage-START> 1200 cGy <RT_Dosage-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_Dosage-START> 45 to 50.4 Gy <RT_Dosage-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> given
None	daily fractions <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	daily fractions 1.80-Gy fractions given focally at a single dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_Dosage-START> 10 to 12 Gy <RT_Dosage-END> total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_Dosage-START> 45 to 50.4 Gy <RT_Dosage-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> given to sites of primary
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_Dosage-START> 10 to 12 Gy <RT_Dosage-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_Dosage-START> 1200 cGy <RT_Dosage-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> to primary extranodal disease at physician discretion to
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_Dosage-START> 10 to 12 Gy <RT_Dosage-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_Dosage-START> 1200 cGy <RT_Dosage-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_Dosage-START> 45 to 50.4 Gy <RT_Dosage-END> total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) .
None	the first ipilimumab dose with a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy <RT_Dosage-START> 10 to 12 Gy <RT_Dosage-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_Dosage-START> 1200 cGy <RT_Dosage-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_Dosage-START> 45 to 50.4 Gy <RT_Dosage-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_Dosage-START> 64 Gy <RT_Dosage-END> 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_Dosage-START> 54 Gy <RT_Dosage-END> Minimum total
None	<RT_Dosage-START> 10 to 12 Gy <RT_Dosage-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total <RT_Dosage-START> 1200 cGy <RT_Dosage-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_Dosage-START> 45 to 50.4 Gy <RT_Dosage-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> given in 25 fractions with cycles 3 and 4 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
DOSE-DOSE	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_Dosage-START> 64 Gy <RT_Dosage-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_Dosage-START> 54 Gy <RT_Dosage-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_Dosage-START> 50 Gy <RT_Dosage-END> for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_Dosage-START> 66 Gy <RT_Dosage-END> for
None	dosage was limited to 800 cGy ) <RT_Dosage-START> 45 to 50.4 Gy <RT_Dosage-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
DOSE-DOSE	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> given to sites of primary bulky disease ; 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_Dosage-START> 64 Gy <RT_Dosage-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_Dosage-START> 54 Gy <RT_Dosage-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_Dosage-START> 50 Gy <RT_Dosage-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_Dosage-START> 66 Gy <RT_Dosage-END> for nodes less than or equal to 2 cm in size ; 70
None	28 fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . <RT_Dosage-START> 64 Gy <RT_Dosage-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy <RT_Dosage-START> 54 Gy <RT_Dosage-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_Dosage-START> 50 Gy <RT_Dosage-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_Dosage-START> 66 Gy <RT_Dosage-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_Dosage-START> 70 Gy <RT_Dosage-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_Dosage-START> 60 Gy <RT_Dosage-END> to the tumor bulk ,
None	25 fractions total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> <RT_Dosage-START> 54 Gy <RT_Dosage-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is <RT_Dosage-START> 50 Gy <RT_Dosage-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_Dosage-START> 66 Gy <RT_Dosage-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_Dosage-START> 70 Gy <RT_Dosage-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_Dosage-START> 60 Gy <RT_Dosage-END> to the tumor bulk , with the tumor-bearing compartment receiving
None	total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_Dosage-START> 64 Gy <RT_Dosage-END> <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is <RT_Dosage-START> 50 Gy <RT_Dosage-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_Dosage-START> 66 Gy <RT_Dosage-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_Dosage-START> 70 Gy <RT_Dosage-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_Dosage-START> 60 Gy <RT_Dosage-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	3 and 4 <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_Dosage-START> 64 Gy <RT_Dosage-END> 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_Dosage-START> 54 Gy <RT_Dosage-END> Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; <RT_Dosage-START> 66 Gy <RT_Dosage-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_Dosage-START> 70 Gy <RT_Dosage-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_Dosage-START> 60 Gy <RT_Dosage-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> total given in 10 fractions from
None	40 Gy given to sites of primary bulky disease ; <RT_Dosage-START> 30 to 40 Gy <RT_Dosage-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_Dosage-START> 64 Gy <RT_Dosage-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_Dosage-START> 54 Gy <RT_Dosage-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_Dosage-START> 50 Gy <RT_Dosage-END> for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; <RT_Dosage-START> 70 Gy <RT_Dosage-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_Dosage-START> 60 Gy <RT_Dosage-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> total given in 10 fractions from days 1 to 12 30
None	to primary extranodal disease at physician discretion to primary tumor ( <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_Dosage-START> 64 Gy <RT_Dosage-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_Dosage-START> 54 Gy <RT_Dosage-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_Dosage-START> 50 Gy <RT_Dosage-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_Dosage-START> 66 Gy <RT_Dosage-END> for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . <RT_Dosage-START> 60 Gy <RT_Dosage-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_Dosage-START> 30 Gy <RT_Dosage-END> total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_Dosage-START> 64 to 66 Gy <RT_Dosage-END> .
None	tumor ( <RT_Dosage-START> 70 to 74 Gy <RT_Dosage-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . <RT_Dosage-START> 64 Gy <RT_Dosage-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy <RT_Dosage-START> 54 Gy <RT_Dosage-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_Dosage-START> 50 Gy <RT_Dosage-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_Dosage-START> 66 Gy <RT_Dosage-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_Dosage-START> 70 Gy <RT_Dosage-END> for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_Dosage-START> 30 Gy <RT_Dosage-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_Dosage-START> 64 to 66 Gy <RT_Dosage-END> . No further details given about fractionation , schedule , or
None	Minimum total dose to neck nodes is <RT_Dosage-START> 50 Gy <RT_Dosage-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_Dosage-START> 66 Gy <RT_Dosage-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_Dosage-START> 70 Gy <RT_Dosage-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_Dosage-START> 60 Gy <RT_Dosage-END> to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> <RT_Dosage-START> 24 Gy <RT_Dosage-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 <RT_Dosage-START> 30 Gy <RT_Dosage-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_Dosage-START> 64 to 66 Gy <RT_Dosage-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_Dosage-START> 40 Gy <RT_Dosage-END> in daily fractions of 1.80 to
None	dose to neck nodes is <RT_Dosage-START> 50 Gy <RT_Dosage-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; <RT_Dosage-START> 66 Gy <RT_Dosage-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_Dosage-START> 70 Gy <RT_Dosage-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_Dosage-START> 60 Gy <RT_Dosage-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 <RT_Dosage-START> 30 Gy <RT_Dosage-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_Dosage-START> 64 to 66 Gy <RT_Dosage-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_Dosage-START> 40 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END>
None	for nodes less than or equal to 2 cm in size ; <RT_Dosage-START> 70 Gy <RT_Dosage-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_Dosage-START> 60 Gy <RT_Dosage-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of <RT_Dosage-START> 64 to 66 Gy <RT_Dosage-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_Dosage-START> 40 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> )
None	in size ; <RT_Dosage-START> 70 Gy <RT_Dosage-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . <RT_Dosage-START> 60 Gy <RT_Dosage-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_Dosage-START> 30 Gy <RT_Dosage-END> total dose to the bladder of 64 to <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_Dosage-START> 40 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) 2 Gy fractions given 5 days per week , with
None	tumor-bearing compartment receiving at least <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
None	tumor-bearing compartment receiving at least 44.8 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
None	tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_Dosage-START> 30 Gy <RT_Dosage-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
None	tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_Dosage-START> 64 to 66 Gy <RT_Dosage-END> . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
DOSE-DOSE	tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
None	tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
None	tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
None	tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to
None	Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per
None	Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_Dosage-START> 30 Gy <RT_Dosage-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per
None	Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_Dosage-START> 64 to 66 Gy <RT_Dosage-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per
DOSE-DOSE	Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_Dosage-START> 40 Gy <RT_Dosage-END> in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per
None	Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per
None	Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per
None	Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to 72 Gy at 180 to 200 cGy per
None	Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_Dosage-START> 68 to 72 Gy <RT_Dosage-END> at 180 to 200 cGy per
None	Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per
None	given in 10 fractions from days 1 to 12 <RT_Dosage-START> 30 Gy <RT_Dosage-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8
None	given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_Dosage-START> 64 to 66 Gy <RT_Dosage-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8
None	given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_Dosage-START> 40 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8
None	given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8
DOSE-DOSE	given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8
None	given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8
None	given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_Dosage-START> 68 to 72 Gy <RT_Dosage-END> at 180 to 200 cGy per day 64.8
None	given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per day 64.8
None	<RT_Dosage-START> 30 Gy <RT_Dosage-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
None	30 Gy total dose to the bladder of <RT_Dosage-START> 64 to 66 Gy <RT_Dosage-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_Dosage-START> 40 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
DOSE-DOSE	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_Dosage-START> 68 to 72 Gy <RT_Dosage-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> in 36 daily fractions of 1.80 Gy 2
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> 2
None	. <RT_Dosage-START> 40 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> <RT_Dosage-START> 68 to 72 Gy <RT_Dosage-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total
None	Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
DOSE-DOSE	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> ,
None	<RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to 72 Gy at 180 to <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
DOSE-DOSE	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_Dosage-START> 68 to 72 Gy <RT_Dosage-END> at 180 to <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 1.8
None	twice per day fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_Dosage-START> 68 to 72 Gy <RT_Dosage-END> at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
DOSE-DOSE	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> fractions ,
None	: <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_Dosage-START> 68 to 72 Gy <RT_Dosage-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
DOSE-DOSE	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> fractions , to start within 24 hours of the
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_Dosage-START> 68 to 72 Gy <RT_Dosage-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
DOSE-DOSE	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> fractions , to start within 24 hours of the start of chemotherapy
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_Dosage-START> 68 to 72 Gy <RT_Dosage-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
DOSE-DOSE	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in
None	Total dose to regional lymph nodes <RT_Dosage-START> 60 Gy <RT_Dosage-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy <RT_Dosage-START> 68 to 72 Gy <RT_Dosage-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
DOSE-DOSE	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> ( details not
None	72 Gy at <RT_Dosage-START> 180 to 200 cGy <RT_Dosage-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
DOSE-DOSE	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	per day <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for
None	66 Gy ) , given 5 days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions 2 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	days per week in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	days per week in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> <RT_Dosage-START> 18 Gy <RT_Dosage-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_Dosage-START> 46.0 to 50.4 Gy <RT_Dosage-END> 45 Gy 2
None	days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2
None	in <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	in 2 Gy fractions once per day x 4 = total dose of <RT_Dosage-START> 8 Gy <RT_Dosage-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_Dosage-START> 46.0 to 50.4 Gy <RT_Dosage-END> 45 Gy 2 Gy at a
None	in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2 Gy at a
None	in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> at a
None	Gy , without lung shielding <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in
None	Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in
None	Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in
None	Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in
DOSE-DOSE	Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_Dosage-START> 46.0 to 50.4 Gy <RT_Dosage-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in
None	Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in
None	Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in
None	Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_Dosage-START> 60 Gy <RT_Dosage-END> , details not available in
None	<RT_Dosage-START> 50.4 Gy <RT_Dosage-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week .
None	50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week .
None	50.4 Gy in 28 fractions 2 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week .
DOSE-DOSE	50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week .
None	50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week .
None	50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week .
None	50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_Dosage-START> 60 Gy <RT_Dosage-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week .
None	50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions ( median total dose : 40 Gy ) , given 5 times per week .
None	50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_Dosage-START> 40 Gy <RT_Dosage-END> ) , given 5 times per week .
None	<RT_Dosage-START> 2 Gy <RT_Dosage-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions
None	2 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions
None	2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions
None	2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_Dosage-START> 46.0 to 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions
None	2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> <RT_Dosage-START> 2 Gy <RT_Dosage-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions
None	2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_Dosage-START> 60 Gy <RT_Dosage-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions
None	2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions
None	2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_Dosage-START> 40 Gy <RT_Dosage-END> ) , given 5 times per week . 1.20 Gy fractions
None	2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_Dosage-START> 1.20 Gy <RT_Dosage-END> fractions
None	<RT_Dosage-START> 18 Gy <RT_Dosage-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose
None	18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose
None	18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_Dosage-START> 46.0 to 50.4 Gy <RT_Dosage-END> 45 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose
None	18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_Dosage-START> 45 Gy <RT_Dosage-END> <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose
None	18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 <RT_Dosage-START> 60 Gy <RT_Dosage-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose
None	18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose
None	18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_Dosage-START> 40 Gy <RT_Dosage-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose
None	18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_Dosage-START> 1.20 Gy <RT_Dosage-END> fractions ( total dose
None	4 : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_Dosage-START> 46.0 to 50.4 Gy <RT_Dosage-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_Dosage-START> 40 Gy <RT_Dosage-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_Dosage-START> 1.20 Gy <RT_Dosage-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) , given twice per day for 5 days per week
None	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_Dosage-START> 46.0 to 50.4 Gy <RT_Dosage-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
None	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
None	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
None	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_Dosage-START> 60 Gy <RT_Dosage-END> , details not available in abstract to the primary tumor , 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
DOSE-DOSE	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : <RT_Dosage-START> 40 Gy <RT_Dosage-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
None	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_Dosage-START> 1.20 Gy <RT_Dosage-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
None	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
None	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END>
None	weeks and a total dose of <RT_Dosage-START> 46.0 to 50.4 Gy <RT_Dosage-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy <RT_Dosage-START> 45 Gy <RT_Dosage-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_Dosage-START> 60 Gy <RT_Dosage-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
DOSE-DOSE	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . <RT_Dosage-START> 1.20 Gy <RT_Dosage-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END> 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions once per day ,
None	<RT_Dosage-START> 45 Gy <RT_Dosage-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
None	45 Gy <RT_Dosage-START> 2 Gy <RT_Dosage-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_Dosage-START> 60 Gy <RT_Dosage-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_Dosage-START> 40 Gy <RT_Dosage-END> ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
DOSE-DOSE	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions once per day , 5 times per week ( total dose : 70 Gy )
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> )
None	rate of 0.07 Gy / min on day 0 <RT_Dosage-START> 60 Gy <RT_Dosage-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_Dosage-START> 40 Gy <RT_Dosage-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
DOSE-DOSE	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_Dosage-START> 1.20 Gy <RT_Dosage-END> fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 46 to 50 Gy in daily
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 46 to 50 Gy <RT_Dosage-END> in daily
None	to 2 Gy fractions ( median total dose : <RT_Dosage-START> 40 Gy <RT_Dosage-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_Dosage-START> 1.20 Gy <RT_Dosage-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 46 to 50 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions
None	median total dose : <RT_Dosage-START> 40 Gy <RT_Dosage-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . <RT_Dosage-START> 1.20 Gy <RT_Dosage-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END> <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
DOSE-DOSE	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 46 to 50 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_Dosage-START> 2 Gy <RT_Dosage-END>
None	<RT_Dosage-START> 1.20 Gy <RT_Dosage-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
DOSE-DOSE	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) <RT_Dosage-START> 46 to 50 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_Dosage-START> 2 Gy <RT_Dosage-END> 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage
None	total dose : <RT_Dosage-START> 69.6 Gy <RT_Dosage-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 46 to <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
DOSE-DOSE	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_Dosage-START> 2 Gy <RT_Dosage-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 46 to 50 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
DOSE-DOSE	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 46 to 50 Gy <RT_Dosage-END> in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_Dosage-START> 2 Gy <RT_Dosage-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	days per week , starting on cycle 1 day 1 to the pelvis , <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 46 to 50 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
DOSE-DOSE	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_Dosage-START> 2 Gy <RT_Dosage-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	to the pelvis , <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 46 to 50 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
DOSE-DOSE	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of <RT_Dosage-START> 2 Gy <RT_Dosage-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy <RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_Dosage-START> 250 cGy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END>
None	, <RT_Dosage-START> 40 to 50 Gy <RT_Dosage-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 46 to 50 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
DOSE-DOSE	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of <RT_Dosage-START> 2 Gy <RT_Dosage-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy <RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_Dosage-START> 250 cGy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) hyperfractionated
None	Gy fractions once per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 46 to 50 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
DOSE-DOSE	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> <RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_Dosage-START> 250 cGy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_Dosage-START> 70.6 Gy <RT_Dosage-END> 2.5
None	per day , 5 times per week ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) <RT_Dosage-START> 46 to 50 Gy <RT_Dosage-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_Dosage-START> 1.80 to 2.00 Gy <RT_Dosage-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 66 Gy in 33 daily fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_Dosage-START> 2 Gy <RT_Dosage-END> 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_Dosage-START> 250 cGy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_Dosage-START> 70.6 Gy <RT_Dosage-END> 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions twice per day
None	fractions x 25 fractions for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	fractions x 25 fractions for a total dose of 45 Gy <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_Dosage-START> 2 Gy <RT_Dosage-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
DOSE-DOSE	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_Dosage-START> 70.6 Gy <RT_Dosage-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	Gy <RT_Dosage-START> 66 Gy <RT_Dosage-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
None	Gy 66 Gy in 33 daily fractions of <RT_Dosage-START> 2 Gy <RT_Dosage-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
None	Gy 66 Gy in 33 daily fractions of 2 Gy <RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
DOSE-DOSE	Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_Dosage-START> 250 cGy <RT_Dosage-END> fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
None	Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose <RT_Dosage-START> 70.6 Gy <RT_Dosage-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
None	Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
None	Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) , administered to the whole bladder and
None	of <RT_Dosage-START> 2 Gy <RT_Dosage-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose
None	of 2 Gy <RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose
None	of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_Dosage-START> 250 cGy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose
None	of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose
None	of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose
None	of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) , administered to the whole bladder and bladder tumor volume . The total dose
None	<RT_Dosage-START> 25 to 30 Gy <RT_Dosage-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole
None	25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_Dosage-START> 250 cGy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole
None	25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) hyperfractionated to total dose 70.6 Gy <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole
None	25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_Dosage-START> 70.6 Gy <RT_Dosage-END> <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole
DOSE-DOSE	25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole
None	x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
None	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_Dosage-START> 70.6 Gy <RT_Dosage-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
DOSE-DOSE	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
None	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_Dosage-START> 44 Gy <RT_Dosage-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
None	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_Dosage-START> 24 Gy <RT_Dosage-END> in 8 fractions . in 3 Gy fractions once per
None	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions once per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_Dosage-START> 24 Gy <RT_Dosage-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_Dosage-START> 12 Gy <RT_Dosage-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_Dosage-START> 20 Gy <RT_Dosage-END> 40 Gy in 20 fractions of 2.00 Gy per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 20 fractions of 2.00 Gy per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per
None	3 , 15 , 17 ( total consolidation dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_Dosage-START> 44 Gy <RT_Dosage-END> in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_Dosage-START> 12 Gy <RT_Dosage-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_Dosage-START> 20 Gy <RT_Dosage-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the pelvis on days 1 to 10 ,
None	dose : <RT_Dosage-START> 20 Gy <RT_Dosage-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_Dosage-START> 44 Gy <RT_Dosage-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_Dosage-START> 24 Gy <RT_Dosage-END> in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
DOSE-DOSE	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of <RT_Dosage-START> 12 Gy <RT_Dosage-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_Dosage-START> 20 Gy <RT_Dosage-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder
None	The total dose to the whole bladder and bladder tumor volume was <RT_Dosage-START> 44 Gy <RT_Dosage-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_Dosage-START> 24 Gy <RT_Dosage-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
DOSE-DOSE	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> <RT_Dosage-START> 20 Gy <RT_Dosage-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days
None	to the whole bladder and bladder tumor volume was <RT_Dosage-START> 44 Gy <RT_Dosage-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_Dosage-START> 24 Gy <RT_Dosage-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_Dosage-START> 12 Gy <RT_Dosage-END> <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days 15 to 20
None	bladder and bladder tumor volume was <RT_Dosage-START> 44 Gy <RT_Dosage-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_Dosage-START> 24 Gy <RT_Dosage-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_Dosage-START> 12 Gy <RT_Dosage-END> 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_Dosage-START> 20 Gy <RT_Dosage-END> <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
DOSE-DOSE	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_Dosage-START> 30 Gy <RT_Dosage-END>
None	<RT_Dosage-START> 44 Gy <RT_Dosage-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_Dosage-START> 24 Gy <RT_Dosage-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_Dosage-START> 12 Gy <RT_Dosage-END> 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_Dosage-START> 20 Gy <RT_Dosage-END> 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
DOSE-DOSE	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_Dosage-START> 30 Gy <RT_Dosage-END> ( see note ) with 1.8
None	; the total dose to the pelvic lymph nodes was <RT_Dosage-START> 24 Gy <RT_Dosage-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_Dosage-START> 12 Gy <RT_Dosage-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_Dosage-START> 20 Gy <RT_Dosage-END> 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_Dosage-START> 30 Gy <RT_Dosage-END> ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions for
None	fractions . in <RT_Dosage-START> 3 Gy <RT_Dosage-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_Dosage-START> 12 Gy <RT_Dosage-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_Dosage-START> 20 Gy <RT_Dosage-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_Dosage-START> 30 Gy <RT_Dosage-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> to 50.4 Gy in 28 fractions
None	to - 3 = total dose of <RT_Dosage-START> 12 Gy <RT_Dosage-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy <RT_Dosage-START> 20 Gy <RT_Dosage-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy <RT_Dosage-START> 40 Gy <RT_Dosage-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 <RT_Dosage-START> 30 Gy <RT_Dosage-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given
None	Gy in 20 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to
None	per fraction <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_Dosage-START> 30 Gy <RT_Dosage-END> ( see note ) with 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
DOSE-DOSE	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites ,
None	on days 1 to 10 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_Dosage-START> 30 Gy <RT_Dosage-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
DOSE-DOSE	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x
None	day to the bladder on days 11 to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_Dosage-START> 30 Gy <RT_Dosage-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
DOSE-DOSE	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for
None	to 14 , then <RT_Dosage-START> 2 Gy <RT_Dosage-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_Dosage-START> 30 Gy <RT_Dosage-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
DOSE-DOSE	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to
None	on days 15 to 20 <RT_Dosage-START> 30 Gy <RT_Dosage-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6
None	<RT_Dosage-START> 30 Gy <RT_Dosage-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to
None	with <RT_Dosage-START> 1.8 to 2 Gy <RT_Dosage-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in
None	to 50.4 Gy in 28 fractions <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
DOSE-DOSE	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction
None	<RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
DOSE-DOSE	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	Gy ) , given 5 times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ; total dose to
None	times per week <RT_Dosage-START> 40 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , <RT_Dosage-START> 30.6 Gy <RT_Dosage-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ; total dose to lymph nodes is
None	Gy to uninvolved sites <RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_Dosage-START> 45.6 Gy <RT_Dosage-END> . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_Dosage-START> 20 Gy <RT_Dosage-END> in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_Dosage-START> 54.4 Gy <RT_Dosage-END>
None	<RT_Dosage-START> 36 Gy <RT_Dosage-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
DOSE-DOSE	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_Dosage-START> 45.6 Gy <RT_Dosage-END> . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_Dosage-START> 20 Gy <RT_Dosage-END> in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_Dosage-START> 54.4 Gy <RT_Dosage-END> for a total
None	sites , 30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in 12 to 14 fractions of 1.50 to <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
DOSE-DOSE	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_Dosage-START> 45.6 Gy <RT_Dosage-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_Dosage-START> 20 Gy <RT_Dosage-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_Dosage-START> 54.4 Gy <RT_Dosage-END> for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_Dosage-START> 61.2 Gy <RT_Dosage-END>
None	30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is <RT_Dosage-START> 45.6 Gy <RT_Dosage-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . <RT_Dosage-START> 20 Gy <RT_Dosage-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_Dosage-START> 54.4 Gy <RT_Dosage-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_Dosage-START> 61.2 Gy <RT_Dosage-END>
None	30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . <RT_Dosage-START> 20 Gy <RT_Dosage-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions <RT_Dosage-START> 54.4 Gy <RT_Dosage-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_Dosage-START> 61.2 Gy <RT_Dosage-END>
None	30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_Dosage-START> 45.6 Gy <RT_Dosage-END> . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions <RT_Dosage-START> 54.4 Gy <RT_Dosage-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of <RT_Dosage-START> 61.2 Gy <RT_Dosage-END>
None	30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_Dosage-START> 45.6 Gy <RT_Dosage-END> . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_Dosage-START> 20 Gy <RT_Dosage-END> in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of <RT_Dosage-START> 61.2 Gy <RT_Dosage-END>
None	30.6 Gy to uninvolved sites 30 x <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_Dosage-START> 60 Gy <RT_Dosage-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_Dosage-START> 24 to 36 Gy <RT_Dosage-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_Dosage-START> 24 Gy <RT_Dosage-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_Dosage-START> 40 to 44 Gy <RT_Dosage-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_Dosage-START> 21 Gy <RT_Dosage-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_Dosage-START> 1.50 to 1.75 Gy <RT_Dosage-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_Dosage-START> 64.8 Gy <RT_Dosage-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_Dosage-START> 45.6 Gy <RT_Dosage-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_Dosage-START> 20 Gy <RT_Dosage-END> in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_Dosage-START> 54.4 Gy <RT_Dosage-END> for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given <FractionFrequency-START> 5 days per week <FractionFrequency-END>
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given <FractionFrequency-START> 5 days per week <FractionFrequency-END> , for a total dose of
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given <FractionFrequency-START> 5 days per week <FractionFrequency-END> , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given <FractionFrequency-START> 5 days per week <FractionFrequency-END> , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
DOSE-FXFREQ	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given <FractionFrequency-START> 5 days per week <FractionFrequency-END> , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
DOSE-FXFREQ	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given <FractionFrequency-START> 5 days per week <FractionFrequency-END> , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given <FractionFrequency-START> 5 days per week <FractionFrequency-END> , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given <FractionFrequency-START> 5 days per week <FractionFrequency-END> , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	28 fractions given <FractionFrequency-START> 5 days per week <FractionFrequency-END> , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
None	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week , <FractionFrequency-END> with
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week , <FractionFrequency-END> with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week , <FractionFrequency-END> with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week , <FractionFrequency-END> with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
DOSE-FXFREQ	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week , <FractionFrequency-END> with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
DOSE-FXFREQ	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 times per week , <FractionFrequency-END> with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week , <FractionFrequency-END> with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	<FractionFrequency-START> 5 times per week , <FractionFrequency-END> with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END>
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 2
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 2 , 3 , 5 , 6 , 8
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
DOSE-FXFREQ	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 5
DOSE-FXFREQ	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 5 fractions ( total dose : 20 Gy ) 2
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 2.10 Gy fractions x
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
DOSE-FXFREQ	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose : 60 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
DOSE-FXFREQ	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
DOSE-FXFREQ	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
DOSE-FXFREQ	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
None	( total dose : 70 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions <FractionFrequency-START> twice per day , <FractionFrequency-END> with
None	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions <FractionFrequency-START> twice per day , <FractionFrequency-END> with the first fraction of each
None	dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions <FractionFrequency-START> twice per day , <FractionFrequency-END> with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 ,
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 27 fractions . 3 Gy fractions <FractionFrequency-START> twice per day , <FractionFrequency-END> with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction
DOSE-FXFREQ	for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions <FractionFrequency-START> twice per day , <FractionFrequency-END> with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered
DOSE-FXFREQ	. 3 Gy fractions <FractionFrequency-START> twice per day , <FractionFrequency-END> with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 77 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 77 Gy ) 1.8 Gy
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 1.8
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
DOSE-FXFREQ	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
DOSE-FXFREQ	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
DOSE-FXFREQ	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
DOSE-FXFREQ	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
DOSE-FXFREQ	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
DOSE-FXFREQ	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	Gy fractions x 70 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	total dose : 77 Gy ) 1.8 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	<FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 15 fractions over 3 weeks ,
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
DOSE-FXFREQ	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
None	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
DOSE-FXFREQ	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
None	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
None	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
DOSE-FXFREQ	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
None	Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions (
DOSE-FXFREQ	Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions (
None	Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 or more hours between fractions ) x 30 fractions (
None	of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
None	of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
None	<FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45
None	twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45
DOSE-FXFREQ	4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7
DOSE-FXFREQ	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
None	) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
None	fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
None	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END>
None	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
DOSE-FXFREQ	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
DOSE-FXFREQ	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 850 to <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 34 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	Gy total ) in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> for a total of 5 fractions (
DOSE-FXFREQ	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
DOSE-FXFREQ	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
DOSE-FXFREQ	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> <FractionFrequency-START> once per day <FractionFrequency-END> for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	( total dose 10 x 3.40 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
DOSE-FXFREQ	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	10 x 3.40 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
None	35 Gy 5.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> , with boost to areas at high risk for malignant dissemination or
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
DOSE-FXFREQ	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
DOSE-FXFREQ	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> x 16 fractions ( total dose :
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
DOSE-FXFREQ	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	, given <FractionFrequency-START> 5 times per week <FractionFrequency-END> , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
DOSE-FXFREQ	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20
None	( boost dose : 12 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
DOSE-FXFREQ	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 2
DOSE-FXFREQ	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 2 Gy fractions x 35 to 37 fractions ( total dose
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> over 7 to 7.5 weeks 1.8 Gy
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
DOSE-FXFREQ	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
DOSE-FXFREQ	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
DOSE-FXFREQ	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	given <FractionFrequency-START> 6 times per week <FractionFrequency-END> 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
DOSE-FXFREQ	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	dose : 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	dose : 70 to 74 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
DOSE-FXFREQ	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
DOSE-FXFREQ	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x
None	64 Gy ) 28 x 1.80 Gy fractions , <FractionFrequency-START> five days per week , <FractionFrequency-END> for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x 2.67 Gy fractions
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 40.05
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 40.05 Gy 1.8
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
DOSE-FXFREQ	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
DOSE-FXFREQ	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
DOSE-FXFREQ	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
DOSE-FXFREQ	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	70.2 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
None	70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
None	70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at
None	given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but
None	given 5 times per week 15 x 2.67 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but
None	given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but
None	, <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	, five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
DOSE-FXFREQ	, for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks . Skarlos et al . 2001 examined two different timings for radiation therapy . There was no significant difference between
DOSE-FXFREQ	fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks . Skarlos et al . 2001 examined two different timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1
None	timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose :
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
DOSE-FXFREQ	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
DOSE-FXFREQ	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	Gy 2.0 Gy fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	fractions given <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy )
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at 50.4 Gy in 28 fractions . was 36 Gy
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END>
DOSE-FXFREQ	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
DOSE-FXFREQ	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
DOSE-FXFREQ	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
DOSE-FXFREQ	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
DOSE-FXFREQ	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in <FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	post-prostatectomy patients 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	<FractionFrequency-START> 5 days per week <FractionFrequency-END> 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , <FractionFrequency-START> 5 days per week <FractionFrequency-END> at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	Gy in 15 <FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	<FractionFrequency-START> daily <FractionFrequency-END> fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	<FractionFrequency-START> daily <FractionFrequency-END> fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy <FractionFrequency-START> twice per day <FractionFrequency-END> fractions ( total dose : 69.6 Gy )
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy <FractionFrequency-START> twice per day <FractionFrequency-END> fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
DOSE-FXFREQ	tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
None	tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy <FractionFrequency-START> twice per day <FractionFrequency-END> fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
DOSE-FXFREQ	Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per
None	Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy <FractionFrequency-START> twice per day <FractionFrequency-END> fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per
None	given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8
DOSE-FXFREQ	given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> <FractionFrequency-START> twice per day <FractionFrequency-END> fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8
None	given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy <FractionFrequency-START> per day <FractionFrequency-END> 64.8
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
DOSE-FXFREQ	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy <FractionFrequency-START> twice per day <FractionFrequency-END> fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy <FractionFrequency-START> per day <FractionFrequency-END> 64.8 Gy in 36 daily fractions of 1.80 Gy 2
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 Gy 2
None	. 40 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy <FractionFrequency-START> twice per day <FractionFrequency-END> fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy <FractionFrequency-START> per day <FractionFrequency-END> 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total
None	Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy <FractionFrequency-START> twice per day <FractionFrequency-END> fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
DOSE-FXFREQ	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy <FractionFrequency-START> per day <FractionFrequency-END> 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy ,
None	1.80 to 2.00 Gy 1.2 Gy <FractionFrequency-START> twice per day <FractionFrequency-END> fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
DOSE-FXFREQ	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> <FractionFrequency-START> per day <FractionFrequency-END> 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 1.8
None	<FractionFrequency-START> twice per day <FractionFrequency-END> fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy <FractionFrequency-START> per day <FractionFrequency-END> <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
DOSE-FXFREQ	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy <FractionFrequency-START> per day <FractionFrequency-END> 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
DOSE-FXFREQ	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy <FractionFrequency-START> per day <FractionFrequency-END> 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
DOSE-FXFREQ	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy <FractionFrequency-START> per day <FractionFrequency-END> 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
DOSE-FXFREQ	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy <FractionFrequency-START> per day <FractionFrequency-END> 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
DOSE-FXFREQ	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	72 Gy at 180 to 200 cGy <FractionFrequency-START> per day <FractionFrequency-END> 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
DOSE-FXFREQ	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	<FractionFrequency-START> per day <FractionFrequency-END> 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	66 Gy ) , given <FractionFrequency-START> 5 days per week <FractionFrequency-END> in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	66 Gy ) , given 5 days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	days per week in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	in 2 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> .
None	2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> . 1.20 Gy fractions
None	18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> . 1.20 Gy fractions ( total dose
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given <FractionFrequency-START> twice per day <FractionFrequency-END> for 5 days per week
DOSE-FXFREQ	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
None	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given <FractionFrequency-START> twice per day <FractionFrequency-END> for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
None	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for <FractionFrequency-START> 5 days per week , <FractionFrequency-END> starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
DOSE-FXFREQ	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given <FractionFrequency-START> twice per day <FractionFrequency-END> for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for <FractionFrequency-START> 5 days per week , <FractionFrequency-END> starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> ,
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
DOSE-FXFREQ	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given <FractionFrequency-START> twice per day <FractionFrequency-END> for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
DOSE-FXFREQ	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for <FractionFrequency-START> 5 days per week , <FractionFrequency-END> starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : 70 Gy )
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy )
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
DOSE-FXFREQ	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> twice per day <FractionFrequency-END> for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
DOSE-FXFREQ	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for <FractionFrequency-START> 5 days per week , <FractionFrequency-END> starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 46 to 50 Gy in daily
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in <FractionFrequency-START> daily <FractionFrequency-END>
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given <FractionFrequency-START> twice per day <FractionFrequency-END> for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for <FractionFrequency-START> 5 days per week , <FractionFrequency-END> starting on cycle 1 day 1 to the pelvis , 40 to <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions
None	median total dose : 40 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given <FractionFrequency-START> twice per day <FractionFrequency-END> for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for <FractionFrequency-START> 5 days per week , <FractionFrequency-END> starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
DOSE-FXFREQ	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
DOSE-FXFREQ	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 2 Gy
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given <FractionFrequency-START> twice per day <FractionFrequency-END> for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for <FractionFrequency-START> 5 days per week , <FractionFrequency-END> starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
DOSE-FXFREQ	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
DOSE-FXFREQ	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	total dose : 69.6 Gy ) , given <FractionFrequency-START> twice per day <FractionFrequency-END> for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for <FractionFrequency-START> 5 days per week , <FractionFrequency-END> starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : 70 Gy ) 46 to <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 46 to <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
DOSE-FXFREQ	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	<FractionFrequency-START> twice per day <FractionFrequency-END> for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for <FractionFrequency-START> 5 days per week , <FractionFrequency-END> starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
DOSE-FXFREQ	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	, 40 to 50 Gy 2.0 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
DOSE-FXFREQ	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
DOSE-FXFREQ	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in <FractionFrequency-START> daily <FractionFrequency-END> fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END>
None	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	Gy 66 Gy in 33 <FractionFrequency-START> daily <FractionFrequency-END> fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
None	Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
None	of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose
DOSE-FXFREQ	25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions <FractionFrequency-START> twice per day <FractionFrequency-END> , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole
DOSE-FXFREQ	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 ,
DOSE-FXFREQ	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions <FractionFrequency-START> once per day <FractionFrequency-END> on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder
DOSE-FXFREQ	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20 30 Gy
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
DOSE-FXFREQ	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	fractions . in 3 Gy fractions <FractionFrequency-START> once per day <FractionFrequency-END> on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
DOSE-FXFREQ	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> <FractionFrequency-START> per day <FractionFrequency-END> to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
DOSE-FXFREQ	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 40 Gy to involved sites , 30.6 Gy to
None	per fraction 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	on days 1 to 10 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	day to the bladder on days 11 to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
DOSE-FXFREQ	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for
None	to 14 , then 2 Gy <FractionFrequency-START> per day <FractionFrequency-END> to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
DOSE-FXFREQ	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
DOSE-FXFREQ	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	58 to 66 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
DOSE-FXFREQ	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , <FractionFrequency-START> five days per week <FractionFrequency-END> , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
DOSE-FXNO	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in <RT_Fraction_Number-START> 1 to 2 <RT_Fraction_Number-END> fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4
None	of 40 Gy to point A given in <RT_Fraction_Number-START> 1 to 2 <RT_Fraction_Number-END> fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4
None	of 40 Gy to point A given in <RT_Fraction_Number-START> 1 to 2 <RT_Fraction_Number-END> fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4 Gy total
None	of 40 Gy to point A given in <RT_Fraction_Number-START> 1 to 2 <RT_Fraction_Number-END> fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4
None	of 40 Gy to point A given in <RT_Fraction_Number-START> 1 to 2 <RT_Fraction_Number-END> fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4
None	of 40 Gy to point A given in <RT_Fraction_Number-START> 1 to 2 <RT_Fraction_Number-END> fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
DOSE-FXNO	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4
DOSE-FXNO	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4 Gy total ) boost to the tumor bed and
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
DOSE-FXNO	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x <RT_Fraction_Number-START> 2 <RT_Fraction_Number-END> fraction ( 3.6 Gy total ) boost to
None	A for a total dose of 75 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
DOSE-FXNO	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x <RT_Fraction_Number-START> 2 <RT_Fraction_Number-END> fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
DOSE-FXNO	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x <RT_Fraction_Number-START> 2 <RT_Fraction_Number-END> fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
DOSE-FXNO	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x <RT_Fraction_Number-START> 2 <RT_Fraction_Number-END> fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( 45 Gy )
None	Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
DOSE-FXNO	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 2 <RT_Fraction_Number-END> fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions given 5 days per week
None	bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
DOSE-FXNO	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x <RT_Fraction_Number-START> 2 <RT_Fraction_Number-END> fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions given 5 days per week , for a total dose of
None	1.8 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x <RT_Fraction_Number-START> 2 <RT_Fraction_Number-END> fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
DOSE-FXNO	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x <RT_Fraction_Number-START> 2 <RT_Fraction_Number-END> fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
DOSE-FXNO	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END>
None	adjacent lymph nodes , and then optionally a 1.8 Gy x <RT_Fraction_Number-START> 2 <RT_Fraction_Number-END> fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
DOSE-FXNO	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
DOSE-FXNO	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given
None	Gy for <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
DOSE-FXNO	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	<RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
DOSE-FXNO	28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
None	28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
None	dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1
DOSE-FXNO	dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1
None	tumor bed . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9
DOSE-FXNO	tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4
None	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~
None	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x <RT_Fraction_Number-START> ~ 32 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5
DOSE-FXNO	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x <RT_Fraction_Number-START> ~ 32 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x <RT_Fraction_Number-START> ~ 32 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
DOSE-FXNO	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x <RT_Fraction_Number-START> ~ 32 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
DOSE-FXNO	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x <RT_Fraction_Number-START> ~ 32 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
DOSE-FXNO	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> ~ 32 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	total dose of 45 Gy , followed by 1.80 Gy x <RT_Fraction_Number-START> 3 <RT_Fraction_Number-END> fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
DOSE-FXNO	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x <RT_Fraction_Number-START> ~ 32 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	for a total dose of 50.4 Gy 1.7 Gy fractions x <RT_Fraction_Number-START> ~ 32 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 45 Gy ) 1.8
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of 45 Gy
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions to the
DOSE-FXNO	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
DOSE-FXNO	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
DOSE-FXNO	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose :
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
DOSE-FXNO	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 60 Gy ) , given 5 times per week
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
DOSE-FXNO	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
DOSE-FXNO	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	( total of 45 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
DOSE-FXNO	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END>
None	<RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
DOSE-FXNO	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 20 Gy ) 2
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
DOSE-FXNO	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	for a total dose of 50.0 Gy 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
DOSE-FXNO	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of
None	for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of
None	dose of 50.0 Gy 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
DOSE-FXNO	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 4 Gy <RT_DOSE-END> fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
DOSE-FXNO	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions (
None	dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions (
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
DOSE-FXNO	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30
None	) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( target dose of 30
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
DOSE-FXNO	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions ,
None	, 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ,
None	1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
DOSE-FXNO	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of
None	1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy total of
None	day x <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
DOSE-FXNO	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on
None	( total dose : 20 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
DOSE-FXNO	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it
None	fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
DOSE-FXNO	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions
None	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
None	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
DOSE-FXNO	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x
None	( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions or 2 Gy x
None	week 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
DOSE-FXNO	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with
None	week 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions . 3 Gy fractions twice per day , with
None	x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
None	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
None	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
DOSE-FXNO	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each
DOSE-FXNO	x 25 fractions over 5 weeks , given during cycle 3 of chemotherapy ( total dose : 52.5 Gy ) 2.0 Gy fractions x 15 fractions ( target dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of <RT_DOSE-START> 54 Gy <RT_DOSE-END> given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions . 3 Gy fractions twice per day , with the first fraction of each
None	dose of 30 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 ,
DOSE-FXNO	dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 ,
DOSE-FXNO	dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 30 fractions or 2 Gy x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 ,
None	dose of 30 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 30 fractions or 2 Gy x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 ,
None	1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction
DOSE-FXNO	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions or <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction
DOSE-FXNO	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_DOSE-START> 2 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 27 fractions . 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total induction
None	for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions or 2 Gy x 27 fractions . <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered
None	for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions . <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered
DOSE-FXNO	for a total dose of 50.4 Gy total of 54 Gy given . Dose per fraction and total duration of treatment were not specified , but based on other regimens , it is suspected to be either 1.8 Gy x 30 fractions or 2 Gy x 27 fractions . <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered
DOSE-FXNO	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
None	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
None	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
None	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for
None	hours after completion of chemotherapy and at least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
DOSE-FXNO	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy
None	between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
DOSE-FXNO	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice
None	<RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
DOSE-FXNO	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
DOSE-FXNO	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
DOSE-FXNO	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
DOSE-FXNO	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
DOSE-FXNO	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase
None	Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of <RT_DOSE-START> 51 Gy <RT_DOSE-END> 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase
None	<RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
DOSE-FXNO	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy
None	25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy <RT_DOSE-START> 1.1 Gy <RT_DOSE-END> fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 25.2 Gy
None	Gy ) 2.0 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
DOSE-FXNO	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions ,
None	Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 77 Gy <RT_DOSE-END> ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ,
None	Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose
None	Gy 1.7 Gy x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an
None	Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an
None	x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
DOSE-FXNO	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8
None	x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8
None	Gy fractions x <RT_Fraction_Number-START> 70 <RT_Fraction_Number-END> fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
DOSE-FXNO	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of
None	Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 25.2 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
DOSE-FXNO	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total
None	total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
DOSE-FXNO	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	5 times per week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) during cycles 1 and 2
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
DOSE-FXNO	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	week ( total dose : 70 Gy ) 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy
None	fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
DOSE-FXNO	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy )
None	fractions x 14 fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy )
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
DOSE-FXNO	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy
None	fractions ( total dose in consolidation phase : 25.2 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2.66 Gy
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
DOSE-FXNO	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks ,
None	total overall dose in induction and consolidation phases : 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions over 3 weeks ,
None	: 64.8 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
DOSE-FXNO	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	: 64.8 Gy ) 1.8 Gy x 25 fractions , for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions over 3 weeks , given during cycle 1 of chemotherapy ( total
None	, for an initial dose of 45 Gy 1.7 Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
DOSE-FXNO	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	, for an initial dose of 45 Gy 1.7 Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given
None	Gy x <RT_Fraction_Number-START> 24 <RT_Fraction_Number-END> fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
DOSE-FXNO	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	Gy x 24 fractions , for an initial dose of 40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably
None	40.8 Gy 2 Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
DOSE-FXNO	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	40.8 Gy 2 Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total
None	Gy per fraction x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
None	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
None	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
DOSE-FXNO	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy
None	Gy per fraction x 25 fractions , total dose of 50 Gy to the primary tumor , 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2.66 Gy <RT_DOSE-END> fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy
None	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
DOSE-FXNO	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
None	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33
None	fractions ( total dose : 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 39.9 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END>
None	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
None	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
DOSE-FXNO	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose
None	: 70 Gy ) during cycles 1 and 2 , 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) 2.66 Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions ( total dose
None	Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions (
DOSE-FXNO	Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions (
None	Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions (
None	Gy fractions once per day x 15 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions (
None	of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
DOSE-FXNO	of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
None	of chemotherapy ( total dose : 39.9 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy
None	twice per day ( at least 4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45
DOSE-FXNO	twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions ( total dose : 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45
None	twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45
None	twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45
None	4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7
None	4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions ( total dose : 60 to 66 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7
DOSE-FXNO	4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( 4 or more hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7
None	4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy . 1.7
None	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
DOSE-FXNO	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
None	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
None	, started on cycle 1 day 2 of chemotherapy 1.80 to 2.00 Gy fractions x 30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x <RT_Fraction_Number-START> 29 <RT_Fraction_Number-END> fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy
None	<RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
DOSE-FXNO	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x <RT_Fraction_Number-START> 29 <RT_Fraction_Number-END> fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy (
None	30 to 33 fractions ( total dose : 60 to 66 Gy ) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 172 cGy (
None	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
DOSE-FXNO	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
None	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x <RT_Fraction_Number-START> 29 <RT_Fraction_Number-END> fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
None	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for
None	) 1.5 Gy fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for
None	fractions given twice per day ( 4 or more hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
None	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
DOSE-FXNO	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 29 <RT_Fraction_Number-END> fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
None	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of
None	fractions given twice per day ( 4 or more hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of
None	fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
DOSE-FXNO	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x <RT_Fraction_Number-START> 29 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x <RT_Fraction_Number-START> 29 <RT_Fraction_Number-END> fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
DOSE-FXNO	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions ,
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ,
None	2 of chemotherapy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x <RT_Fraction_Number-START> 29 <RT_Fraction_Number-END> fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
DOSE-FXNO	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy (
None	1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x <RT_Fraction_Number-START> 29 <RT_Fraction_Number-END> fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
DOSE-FXNO	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	<RT_Fraction_Number-START> 29 <RT_Fraction_Number-END> fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
DOSE-FXNO	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> doses ( 8
None	starting on cycle 1 day 1 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
None	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
DOSE-FXNO	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
None	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> doses ( 8 Gy total ) in 2 Gy fractions once per day
None	50.4 Gy ) 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
DOSE-FXNO	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in <RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
DOSE-FXNO	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in <RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END>
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
DOSE-FXNO	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in <RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose 2 Gy
None	coned-down boost of 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
DOSE-FXNO	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in <RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
DOSE-FXNO	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in <RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose 10 x 3.40 Gy fractions , five days per week
None	, given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x 3.40 Gy fractions , five days per week
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 850 to <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
DOSE-FXNO	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in <RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 850 to 1020 cGy <RT_DOSE-END> in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy
None	) 200 cGy fractions x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in <RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
DOSE-FXNO	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy
None	) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions for a total dose of 35 Gy 5.0 Gy
None	Gy total ) in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in <RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
DOSE-FXNO	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions (
None	Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions (
None	<RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in <RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
DOSE-FXNO	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) 2 Gy fractions x 33
None	4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x <RT_DOSE-START> 3.40 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END>
None	1020 cGy in <RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
DOSE-FXNO	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al
None	1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 34 Gy <RT_DOSE-END> 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) . See Chan et al
None	<RT_Fraction_Number-START> 5 to 6 <RT_Fraction_Number-END> fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
DOSE-FXNO	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy <RT_DOSE-START> 2.33 Gy <RT_DOSE-END> fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) . See Chan et al . 2005
None	1 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
DOSE-FXNO	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of <RT_DOSE-START> 35 Gy <RT_DOSE-END> 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions
None	Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
DOSE-FXNO	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions
None	Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy <RT_DOSE-START> 5.0 Gy <RT_DOSE-END> once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions
None	( total dose <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
DOSE-FXNO	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	( total dose 10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5
None	<RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
DOSE-FXNO	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	10 x 3.40 Gy fractions , five days per week , for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2
None	, for a total dose of 34 Gy 2.33 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
None	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
DOSE-FXNO	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
None	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54
None	, for a total dose of 34 Gy 2.33 Gy fractions x 15 fractions for a total dose of 35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions ( total dose : 54
None	35 Gy 5.0 Gy once per day for a total of <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
DOSE-FXNO	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or
None	) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
DOSE-FXNO	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> fractions ( boost dose : 12 Gy )
None	fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
DOSE-FXNO	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
DOSE-FXNO	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose :
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
DOSE-FXNO	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
None	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions (
None	: 52.5 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
DOSE-FXNO	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> fractions ( boost dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	2 Gy fractions x <RT_Fraction_Number-START> 27 <RT_Fraction_Number-END> fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
DOSE-FXNO	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
DOSE-FXNO	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
DOSE-FXNO	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose :
None	dissemination or that had inadequate resection margins of 2 Gy fractions x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
DOSE-FXNO	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	had inadequate resection margins of 2 Gy fractions x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
DOSE-FXNO	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END>
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
DOSE-FXNO	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	) 1.5 Gy fractions given twice per day x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
DOSE-FXNO	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total
None	) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total
None	x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
DOSE-FXNO	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times
None	x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) , given 5 times
None	total dose : 24 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
DOSE-FXNO	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) , given 5 times per week 2
None	x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
DOSE-FXNO	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose
None	x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x <RT_Fraction_Number-START> 35 to 37 <RT_Fraction_Number-END> fractions ( total dose
None	Gy 2.00 Gy x <RT_Fraction_Number-START> 34 to 35 <RT_Fraction_Number-END> fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
DOSE-FXNO	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x <RT_Fraction_Number-START> 35 to 37 <RT_Fraction_Number-END> fractions ( total dose : 70 to 74 Gy ) , given 5 times
None	total dose of 68 to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
DOSE-FXNO	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x <RT_Fraction_Number-START> 35 to 37 <RT_Fraction_Number-END> fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy
None	to 70 Gy ) 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
DOSE-FXNO	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x <RT_Fraction_Number-START> 35 to 37 <RT_Fraction_Number-END> fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions ,
None	to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ,
None	( total dose : 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
DOSE-FXNO	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x <RT_Fraction_Number-START> 35 to 37 <RT_Fraction_Number-END> fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on
None	( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy , starting on
None	fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
DOSE-FXNO	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 35 to 37 <RT_Fraction_Number-END> fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions
None	given 6 times per week 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
DOSE-FXNO	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x <RT_Fraction_Number-START> 35 to 37 <RT_Fraction_Number-END> fractions ( total dose : 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions ( total dose 1.8 Gy fractions x 14 fractions (
None	given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions (
None	Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x <RT_Fraction_Number-START> 35 to 37 <RT_Fraction_Number-END> fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
DOSE-FXNO	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and
None	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x <RT_Fraction_Number-START> 35 to 37 <RT_Fraction_Number-END> fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
DOSE-FXNO	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	dose : 66 Gy ) , given 5 times per week 2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x
None	2 Gy fractions x <RT_Fraction_Number-START> 35 to 37 <RT_Fraction_Number-END> fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
DOSE-FXNO	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : 64 Gy ) 28 x
None	2 Gy fractions x 35 to 37 fractions ( total dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
DOSE-FXNO	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for
None	dose : 70 to 74 Gy ) , given 5 times per week over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for
None	over 7 to 7.5 weeks 1.8 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
DOSE-FXNO	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions
None	over 7 to 7.5 weeks 1.8 Gy x 25 fractions , for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : <RT_DOSE-START> 39.6 Gy <RT_DOSE-END> ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per
None	for a total dose of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
DOSE-FXNO	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions
None	of 45 Gy , starting on cycle 1 day 0 or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions
None	or 1 1.8 Gy fractions x <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
DOSE-FXNO	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	or 1 1.8 Gy fractions x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : <RT_DOSE-START> 64 Gy <RT_DOSE-END> ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions
None	x <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x <RT_Fraction_Number-START> 14 <RT_Fraction_Number-END> fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
DOSE-FXNO	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a
None	x 18 fractions ( total dose 1.8 Gy fractions x 14 fractions ( total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
DOSE-FXNO	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then
None	total dose in consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
DOSE-FXNO	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions
None	consolidation phase : 39.6 Gy ; total overall dose in induction and consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
DOSE-FXNO	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total
None	consolidation phases : 64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of <RT_DOSE-START> 46 Gy <RT_DOSE-END> 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total
None	64.8 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 32 <RT_Fraction_Number-END> fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
DOSE-FXNO	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2
None	64.8 Gy ) 2 Gy fractions x 32 fractions ( total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : 70.2
None	total dose : 64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
DOSE-FXNO	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x
None	total dose : 64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x
None	64 Gy ) <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
DOSE-FXNO	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions
None	64 Gy ) 28 x 1.80 Gy fractions , five days per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x 2.67 Gy fractions
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
DOSE-FXNO	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	per week , for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x 2.67 Gy fractions , five days per week , for a total dose of 40.05
None	for a total dose of 50.4 Gy 2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
DOSE-FXNO	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	for a total dose of 50.4 Gy 2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8
None	2 Gy fractions x <RT_Fraction_Number-START> 23 <RT_Fraction_Number-END> fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
DOSE-FXNO	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within
None	2 Gy fractions x 23 fractions , for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , starting within
None	for a total dose of 46 Gy 1.8 Gy per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
DOSE-FXNO	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of
None	for a total dose of 46 Gy 1.8 Gy per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , starting within 24 hours of the first dose of
None	per fraction x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
DOSE-FXNO	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	per fraction x 28 fractions , total dose of 50.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : <RT_DOSE-START> 70.2 Gy <RT_DOSE-END> ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy .
None	1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
DOSE-FXNO	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of
None	1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy 1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total of
None	1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
DOSE-FXNO	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	1.8 Gy fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over
None	fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 39 <RT_Fraction_Number-END> fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
DOSE-FXNO	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	fractions x 25 fractions , then 2 Gy fractions x 9 fractions 1.8 Gy fractions x 39 fractions ( total dose : 70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks ,
None	70.2 Gy ) , given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
DOSE-FXNO	70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
None	70.2 Gy ) , given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> . 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at
None	given 5 times per week <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but
None	given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but
DOSE-FXNO	given 5 times per week 15 x 2.67 Gy fractions , five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but
None	, five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
DOSE-FXNO	, five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total
None	, five days per week , for a total dose of 40.05 Gy 1.8 Gy fractions x 25 fractions , starting within 24 hours of the first dose of chemotherapy , for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total
None	, for a total dose of 45 Gy . 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks . Skarlos et al . 2001 examined two different timings for radiation therapy . There was no significant difference between
DOSE-FXNO	, for a total dose of 45 Gy . 1.8 Gy fractions x 28 fractions , for a total of 50.4 Gy 1.50 Gy fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) over 3 weeks . Skarlos et al . 2001 examined two different timings for radiation therapy . There was no significant difference between
DOSE-FXNO	fractions given twice per day x 30 fractions over 3 weeks , given during cycle 1 of chemotherapy ( total dose : 45 Gy ) 1.5 Gy fractions given twice per day ( at least 4 , but preferably 6 hours between fractions ) x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) over 3 weeks . Skarlos et al . 2001 examined two different timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1
DOSE-FXNO	timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose :
None	timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose :
None	timings for radiation therapy . There was no significant difference between early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . <RT_DOSE-START> 2.67 Gy <RT_DOSE-END> fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose :
DOSE-FXNO	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions
None	early vs. late HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of <RT_DOSE-START> 40.05 Gy <RT_DOSE-END> 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an
DOSE-FXNO	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an
None	HTRT , though there was a trend toward higher response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
DOSE-FXNO	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy ,
None	response rate for late HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy ,
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
DOSE-FXNO	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	HTRT . Early HTRT is given during cycle 1 of chemotherapy ; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
DOSE-FXNO	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy
None	; late HTRT is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36
None	is given during cycle 4 of chemotherapy . 2.67 Gy fractions x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36
None	x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	for a total dose of 40.05 Gy 1.8 Gy for <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
DOSE-FXNO	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy +
None	dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
DOSE-FXNO	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END>
None	<RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-FXNO	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy )
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
DOSE-FXNO	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	1.8 Gy fractions x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	x <RT_Fraction_Number-START> 20 to 22 <RT_Fraction_Number-END> fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	36 to 39.6 Gy , started on day 8 1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
DOSE-FXNO	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then
None	1.80 Gy x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
DOSE-FXNO	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
DOSE-FXNO	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	of 70 Gy ) 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
DOSE-FXNO	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
DOSE-FXNO	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
DOSE-FXNO	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	in 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was 36 Gy
None	18 Gy boost in 2.00 Gy fractions x <RT_Fraction_Number-START> 9 <RT_Fraction_Number-END> fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions 36 Gy in daily
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END>
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of 8 Gy per target bone lesion for up
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of 8 Gy per target bone lesion for up to three bone lesions
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
DOSE-FXNO	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
DOSE-FXNO	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
DOSE-FXNO	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	Gy in <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in <RT_Fraction_Number-START> 25 to 28 <RT_Fraction_Number-END> fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in <RT_Fraction_Number-START> 25 to 28 <RT_Fraction_Number-END> fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 1.80-Gy fractions given focally at a <RT_Fraction_Number-START> single <RT_Fraction_Number-END> dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in <RT_Fraction_Number-START> 25 to 28 <RT_Fraction_Number-END> fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
DOSE-FXNO	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in <RT_Fraction_Number-START> 25 to 28 <RT_Fraction_Number-END> fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in <RT_Fraction_Number-START> 25 to 28 <RT_Fraction_Number-END> fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
DOSE-FXNO	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in <RT_Fraction_Number-START> 25 to 28 <RT_Fraction_Number-END> fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
DOSE-FXNO	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in <RT_Fraction_Number-START> 25 to 28 <RT_Fraction_Number-END> fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in <RT_Fraction_Number-START> 25 to 28 <RT_Fraction_Number-END> fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	28 fractions 45 Gy total in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	<RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	total of 50 Gy given in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from days 1 to 12 30
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
DOSE-FXNO	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
None	Gy 24 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per
None	given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8
None	30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of 1.80 Gy 2
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total
None	. 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes <RT_DOSE-START> 60 Gy <RT_DOSE-END> 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy ,
None	Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy <RT_DOSE-START> 68 to 72 Gy <RT_DOSE-END> at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy ,
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8
None	1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at <RT_DOSE-START> 180 to 200 cGy <RT_DOSE-END> per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 1.8
DOSE-FXNO	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
None	twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions ,
DOSE-FXNO	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	: 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
DOSE-FXNO	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions 2 Gy 18 Gy ( details not
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
DOSE-FXNO	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	per day 64.8 Gy in <RT_Fraction_Number-START> 36 <RT_Fraction_Number-END> daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
None	66 Gy ) , given 5 days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
DOSE-FXNO	66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	days per week in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	in 2 Gy fractions once per day x <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in
DOSE-FXNO	Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the primary tumor , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in
None	50.4 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week .
DOSE-FXNO	50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions over 5 to 6 weeks and a total dose of 46.0 to <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week .
None	2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions
None	18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week
None	total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of 2 Gy
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
DOSE-FXNO	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
DOSE-FXNO	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
DOSE-FXNO	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) hyperfractionated
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
DOSE-FXNO	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of 2 Gy 25 to <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
DOSE-FXNO	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	Gy 66 Gy in <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
DOSE-FXNO	Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
None	Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
None	of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose
None	of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose
None	25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole
DOSE-FXNO	25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions twice per day , with at least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole
None	x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
DOSE-FXNO	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
None	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
None	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions . in 3 Gy fractions once per
None	least 4 hours between fractions , x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
DOSE-FXNO	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of 2.00 Gy per
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
DOSE-FXNO	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	to the whole bladder and bladder tumor volume was 44 Gy in <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	bladder and bladder tumor volume was 44 Gy in <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
DOSE-FXNO	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	44 Gy in <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
DOSE-FXNO	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	; the total dose to the pelvic lymph nodes was 24 Gy in <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	Gy in <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
DOSE-FXNO	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction
DOSE-FXNO	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions 54.4 Gy
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
DOSE-FXNO	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions 54.4 Gy for a total
None	sites , 30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
DOSE-FXNO	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
DOSE-FXNO	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites <RT_Fraction_Number-START> 30 <RT_Fraction_Number-END> x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in <RT_Fraction_Number-START> 12 to 14 <RT_Fraction_Number-END> fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
DOSE-SITE	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to <Anatomical_site-START> point A <Anatomical_site-END> given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to <Anatomical_site-START> point A <Anatomical_site-END> with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to <Anatomical_site-START> point A <Anatomical_site-END> 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of <RT_DOSE-START> 40 Gy <RT_DOSE-END> to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to <Anatomical_site-START> point A <Anatomical_site-END> given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
DOSE-SITE	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to <Anatomical_site-START> point A <Anatomical_site-END> with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to <Anatomical_site-START> point A <Anatomical_site-END> 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of <RT_DOSE-START> 81 Gy <RT_DOSE-END> to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to <Anatomical_site-START> point A <Anatomical_site-END> given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to <Anatomical_site-START> point A <Anatomical_site-END> with cesium-137 , with 30 to <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
DOSE-SITE	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to <Anatomical_site-START> point A <Anatomical_site-END> 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with <RT_DOSE-START> 30 to 35 Gy <RT_DOSE-END> delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total
None	of 40 Gy to <Anatomical_site-START> point A <Anatomical_site-END> given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to <Anatomical_site-START> point A <Anatomical_site-END> with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to <Anatomical_site-START> point A <Anatomical_site-END> <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
DOSE-SITE	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to <Anatomical_site-START> point A <Anatomical_site-END> for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to <Anatomical_site-START> point A <Anatomical_site-END> given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to <Anatomical_site-START> point A <Anatomical_site-END> with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to <Anatomical_site-START> point A <Anatomical_site-END> 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of <RT_DOSE-START> 75 Gy <RT_DOSE-END> 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to <Anatomical_site-START> point A <Anatomical_site-END> given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to <Anatomical_site-START> point A <Anatomical_site-END> with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to <Anatomical_site-START> point A <Anatomical_site-END> 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	of 40 Gy to point A given in 1 to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4
None	to 2 fractions for a total dose of 81 Gy to <Anatomical_site-START> point A <Anatomical_site-END> with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to <Anatomical_site-START> point A <Anatomical_site-END> 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and
None	to 2 fractions for a total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and
None	total dose of 81 Gy to <Anatomical_site-START> point A <Anatomical_site-END> with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to <Anatomical_site-START> point A <Anatomical_site-END> 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
DOSE-SITE	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and adjacent lymph nodes , and then
None	total dose of 81 Gy to point A with cesium-137 , with 30 to 35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent <Anatomical_site-START> lymph nodes , <Anatomical_site-END> and then
None	35 Gy delivered to <Anatomical_site-START> point A <Anatomical_site-END> 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent <Anatomical_site-START> lymph nodes , <Anatomical_site-END> and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to
None	35 Gy delivered to point A 30 Gy to point A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent <Anatomical_site-START> lymph nodes , <Anatomical_site-END> and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and a 2 cm margin if the small bowel
None	A for a total dose of 75 Gy 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of <RT_DOSE-START> 45 Gy , <RT_DOSE-END> which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> if the small bowel
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
DOSE-SITE	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
DOSE-SITE	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
DOSE-SITE	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent <Anatomical_site-START> lymph nodes , <Anatomical_site-END> and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and a 2 cm margin if the small bowel could be avoided 1.80 Gy for
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> if the small bowel could be avoided 1.80 Gy for
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
DOSE-SITE	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
DOSE-SITE	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
DOSE-SITE	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent <Anatomical_site-START> lymph nodes , <Anatomical_site-END> and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy )
None	Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent <Anatomical_site-START> lymph nodes , <Anatomical_site-END> and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
DOSE-SITE	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
DOSE-SITE	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
DOSE-SITE	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with <Anatomical_site-START> boost <Anatomical_site-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent <Anatomical_site-START> lymph nodes , <Anatomical_site-END> and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
DOSE-SITE	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
DOSE-SITE	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
DOSE-SITE	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	bed . 1.8 Gy fractions x 25 fractions for an initial dose of 45 Gy , which is followed by a 1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( <RT_DOSE-START> 3.6 Gy <RT_DOSE-END> total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with <Anatomical_site-START> boost <Anatomical_site-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent <Anatomical_site-START> lymph nodes , <Anatomical_site-END> and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with <Anatomical_site-START> boost <Anatomical_site-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy
None	1.8 Gy x 3 fraction ( 5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 172 cGy
None	5.4 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent <Anatomical_site-START> lymph nodes , <Anatomical_site-END> and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with <Anatomical_site-START> boost <Anatomical_site-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25
None	5.4 Gy total ) boost to the tumor bed and adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 172 cGy ( rads ) fractions x 25
None	adjacent <Anatomical_site-START> lymph nodes , <Anatomical_site-END> and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with <Anatomical_site-START> boost <Anatomical_site-END> depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	adjacent lymph nodes , and then optionally a 1.8 Gy x 2 fraction ( 3.6 Gy total ) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose
None	) <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with <Anatomical_site-START> boost <Anatomical_site-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads )
None	) boost to the tumor bed and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads )
None	and a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with <Anatomical_site-START> boost <Anatomical_site-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
DOSE-SITE	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given
None	and a 2 cm margin if the small bowel could be avoided 1.80 Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given
None	Gy for 25 fractions ( 45 Gy ) , with <Anatomical_site-START> boost <Anatomical_site-END> depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	Gy for 25 fractions ( 45 Gy ) , with boost depending on stage 1.8 Gy fractions x 28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
None	28 fractions given 5 days per week , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total
None	dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1
DOSE-SITE	dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1
None	<Anatomical_site-START> tumor bed <Anatomical_site-END> . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down boost of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9
DOSE-SITE	tumor bed . 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4
None	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~
None	1.8 Gy fractions x 28 fractions , total dose of 50.4 Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
None	Gy to the planning target volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> , followed by 1.80 Gy x 3 fractions boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5
DOSE-SITE	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
DOSE-SITE	volume ( PTV-1 ) ; then a boost of 1.8 Gy fractions x 5 fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 3 fractions boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to primary site and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> primary site <Anatomical_site-END> and / or cervical lymph nodes with 1.8 to 2
None	fractions , total boost dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or <Anatomical_site-START> cervical lymph nodes <Anatomical_site-END> with 1.8 to 2
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> primary site <Anatomical_site-END> and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an
None	dose of 9 Gy to the PTV-2 , for a total cumulative dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or <Anatomical_site-START> cervical lymph nodes <Anatomical_site-END> with 1.8 to 2 Gy fractions for an
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> primary site <Anatomical_site-END> and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or <Anatomical_site-START> cervical lymph nodes <Anatomical_site-END> with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt
None	dose of 59.4 Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Anatomical_site-START> boost <Anatomical_site-END> dose of 11 to 16 Gy to close (& lt
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> primary site <Anatomical_site-END> and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or <Anatomical_site-START> cervical lymph nodes <Anatomical_site-END> with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm
None	Gy 1.80 Gy fractions x 25 fractions , for a total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Anatomical_site-START> boost <Anatomical_site-END> dose of 11 to 16 Gy to close (& lt ; 5 mm
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to <Anatomical_site-START> primary site <Anatomical_site-END> and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or <Anatomical_site-START> cervical lymph nodes <Anatomical_site-END> with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Anatomical_site-START> boost <Anatomical_site-END> dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to <Anatomical_site-START> close (& lt ; 5 mm ) <Anatomical_site-END> or positive margin areas of ( overall dose to these
None	total dose of 45 Gy , followed by 1.80 Gy x 3 fractions boost to the tumor bed ( total dose of 50.4 Gy ) 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or <Anatomical_site-START> positive margin areas <Anatomical_site-END> of ( overall dose to these
DOSE-SITE	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
DOSE-SITE	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> primary site <Anatomical_site-END> and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
DOSE-SITE	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or <Anatomical_site-START> cervical lymph nodes <Anatomical_site-END> with 1.8 to 2 Gy fractions for an additional boost dose of 11 to <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
DOSE-SITE	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Anatomical_site-START> boost <Anatomical_site-END> dose of 11 to <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
DOSE-SITE	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to <Anatomical_site-START> close (& lt ; 5 mm ) <Anatomical_site-END> or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
DOSE-SITE	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or <Anatomical_site-START> positive margin areas <Anatomical_site-END> of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A <Anatomical_site-START> boost <Anatomical_site-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ;
None	for a total dose of 50.4 Gy 1.7 Gy fractions x ~ 32 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of <RT_DOSE-START> 11 to 16 Gy <RT_DOSE-END> to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to <Anatomical_site-START> metastatic nodal sites <Anatomical_site-END> ( overall dose to these sites : 65 to 74 Gy ) ;
None	5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to <Anatomical_site-START> primary site <Anatomical_site-END> and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or <Anatomical_site-START> cervical lymph nodes <Anatomical_site-END> with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Anatomical_site-START> boost <Anatomical_site-END> dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to <Anatomical_site-START> close (& lt ; 5 mm ) <Anatomical_site-END> or positive margin areas of ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or <Anatomical_site-START> positive margin areas <Anatomical_site-END> of ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A <Anatomical_site-START> boost <Anatomical_site-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	5 times per week , with boost to primary site and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> ) . A boost of 11 to 20 Gy was given to <Anatomical_site-START> metastatic nodal sites <Anatomical_site-END> ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8
None	and / or <Anatomical_site-START> cervical lymph nodes <Anatomical_site-END> with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional <Anatomical_site-START> boost <Anatomical_site-END> dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to <Anatomical_site-START> close (& lt ; 5 mm ) <Anatomical_site-END> or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or <Anatomical_site-START> positive margin areas <Anatomical_site-END> of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
DOSE-SITE	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A <Anatomical_site-START> boost <Anatomical_site-END> of 11 to <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
DOSE-SITE	and / or cervical lymph nodes with 1.8 to 2 Gy fractions for an additional boost dose of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of <RT_DOSE-START> 11 to 20 Gy <RT_DOSE-END> was given to <Anatomical_site-START> metastatic nodal sites <Anatomical_site-END> ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy
None	of 11 to 16 Gy to <Anatomical_site-START> close (& lt ; 5 mm ) <Anatomical_site-END> or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or <Anatomical_site-START> positive margin areas <Anatomical_site-END> of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A <Anatomical_site-START> boost <Anatomical_site-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of 11 to 16 Gy to close (& lt ; 5 mm ) or positive margin areas of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to <Anatomical_site-START> metastatic nodal sites <Anatomical_site-END> ( overall dose to these sites : 65 to <RT_DOSE-START> 65 to 74 Gy <RT_DOSE-END> ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the
None	of ( overall dose to these sites : 65 to 70 Gy ) . A <Anatomical_site-START> boost <Anatomical_site-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to <Anatomical_site-START> metastatic nodal sites <Anatomical_site-END> ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial <Anatomical_site-START> tumor length <Anatomical_site-END> plus a 5 cm margin , for a total dose of 50.0
None	of ( overall dose to these sites : 65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a <Anatomical_site-START> 5 cm margin , <Anatomical_site-END> for a total dose of 50.0
None	65 to 70 Gy ) . A <Anatomical_site-START> boost <Anatomical_site-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to <Anatomical_site-START> metastatic nodal sites <Anatomical_site-END> ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial <Anatomical_site-START> tumor length <Anatomical_site-END> plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	65 to 70 Gy ) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a <Anatomical_site-START> 5 cm margin , <Anatomical_site-END> for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions
None	) . A <Anatomical_site-START> boost <Anatomical_site-END> of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to <Anatomical_site-START> metastatic nodal sites <Anatomical_site-END> ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial <Anatomical_site-START> tumor length <Anatomical_site-END> plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	) . A boost of 11 to 20 Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a <Anatomical_site-START> 5 cm margin , <Anatomical_site-END> for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose :
None	Gy was given to <Anatomical_site-START> metastatic nodal sites <Anatomical_site-END> ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial <Anatomical_site-START> tumor length <Anatomical_site-END> plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	Gy was given to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a <Anatomical_site-START> 5 cm margin , <Anatomical_site-END> for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week
None	to <Anatomical_site-START> metastatic nodal sites <Anatomical_site-END> ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial <Anatomical_site-START> tumor length <Anatomical_site-END> plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
None	to metastatic nodal sites ( overall dose to these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a <Anatomical_site-START> 5 cm margin , <Anatomical_site-END> for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2
DOSE-SITE	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial <Anatomical_site-START> tumor length <Anatomical_site-END> plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
DOSE-SITE	these sites : 65 to 74 Gy ) ; see Bachaud et al . 1996 for details . 180 cGy x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 10 fractions to the initial tumor length plus a <Anatomical_site-START> 5 cm margin , <Anatomical_site-END> for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial <Anatomical_site-START> tumor length <Anatomical_site-END> plus a 5 cm margin , for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	x 25 fractions ( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a <Anatomical_site-START> 5 cm margin , <Anatomical_site-END> for a total dose of <RT_DOSE-START> 50.0 Gy <RT_DOSE-END> 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial <Anatomical_site-START> tumor length <Anatomical_site-END> plus a 5 cm margin , for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	( total of 45 Gy ) 1.8 Gy x 25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a <Anatomical_site-START> 5 cm margin , <Anatomical_site-END> for a total dose of 50.0 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial <Anatomical_site-START> tumor length <Anatomical_site-END> plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	25 fractions for a total of 45 Gy 2.0 Gy fractions x 15 fractions , then 2.0 Gy fractions x 10 fractions to the initial tumor length plus a <Anatomical_site-START> 5 cm margin , <Anatomical_site-END> for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : <RT_DOSE-START> 60 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 1.8 Gy x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2
None	to the initial <Anatomical_site-START> tumor length <Anatomical_site-END> plus a 5 cm margin , for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
None	to the initial tumor length plus a <Anatomical_site-START> 5 cm margin , <Anatomical_site-END> for a total dose of 50.0 Gy 2 Gy fractions x 30 fractions ( total dose : 60 Gy ) , given 5 times per week on weeks 2 , 3 , 5 , 6 , 8 , 9 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 25 fractions , for an initial dose of 40.8 Gy 4 Gy fractions once per day x 5 fractions ( total dose : 20 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 days per week 2.10 Gy fractions x
DOSE-SITE	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
DOSE-SITE	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
DOSE-SITE	. 3 Gy fractions twice per day , with the first fraction of each day given 1 to 2 hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) , administered to the whole bladder , bladder tumor volume , and <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> , bladder tumor volume , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> , and pelvic lymph nodes . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
None	hours after completion of chemotherapy and at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions ( total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	8 fractions , given on days 1 , 3 , 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	, 15 , 17 ( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy
None	( total induction dose : 24 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> , bladder tumor volume , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	( total induction dose : 24 Gy ) , administered to the whole bladder , bladder tumor volume , and <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.7 Gy x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy
None	<Anatomical_site-START> bladder tumor volume <Anatomical_site-END> , and pelvic lymph nodes . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	bladder tumor volume , and <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions ( total dose of 45 Gy ) 2.0 Gy x 25 fractions ( total dose : 50 Gy ) 2.0 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.7 Gy <RT_DOSE-END> x 30 fractions , for an initial dose of 51 Gy 1.1 Gy fractions x 70 fractions , given twice per day , 5 times per week ( total dose : 77 Gy ) 1.8 Gy fractions given 5 times per week ( total dose : 70 Gy ) 1.8
None	fractions ) x 30 fractions ( total dose : 45 Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of <RT_DOSE-START> 49.3 Gy <RT_DOSE-END> , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of
None	Gy ) over 3 weeks , started on cycle 1 day 2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions ,
None	2 of chemotherapy 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy (
None	1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy . 1.7 Gy x 29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and
None	29 fractions , for a total dose of 49.3 Gy , starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of <RT_DOSE-START> 4300 cGy <RT_DOSE-END> ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8
DOSE-SITE	starting on cycle 1 day 1 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day
DOSE-SITE	50.4 Gy ) 172 cGy ( rads ) fractions x 25 fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of <RT_DOSE-START> 1720 cGy <RT_DOSE-END> ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in
None	fractions , given over 5 weeks for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1
None	for a total dose of 4300 cGy ( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions x 4 doses ( 8 Gy total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28
None	( 4300 rads ) , then coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( <RT_DOSE-START> 8 Gy <RT_DOSE-END> total ) in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy
None	coned-down <Anatomical_site-START> boost <Anatomical_site-END> of 172 cGy ( rads ) fractions x 10 fractions , given over 2 weeks for a dose of 1720 cGy ( rads ) , and a total cumulative dose of 6020 cGy ( rads ) 200 cGy fractions x 4 doses ( 8 Gy total ) in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 850 to 1020 cGy in 5 to 6 fractions delivered on days - 3 to - 1 1.8 Gy fractions x 28 fractions ( total dose 2 Gy fractions x 25 fractions ( total
None	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to areas at high risk for malignant dissemination or
None	35 Gy 5.0 Gy once per day for a total of 5 fractions ( total dose : 25 Gy ) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . <RT_DOSE-START> 2.10 Gy <RT_DOSE-END> fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> areas at high risk <Anatomical_site-END> for malignant dissemination or
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> areas at high risk <Anatomical_site-END> for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had <Anatomical_site-START> inadequate resection margins <Anatomical_site-END> of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy )
None	) 2 Gy fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : <RT_DOSE-START> 52.5 Gy <RT_DOSE-END> ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 Gy )
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> areas at high risk <Anatomical_site-END> for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had <Anatomical_site-START> inadequate resection margins <Anatomical_site-END> of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given
None	fractions x 33 fractions ( total dose : 66 Gy ) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 Gy ) 1.5 Gy fractions given
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to <Anatomical_site-START> areas at high risk <Anatomical_site-END> for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had <Anatomical_site-START> inadequate resection margins <Anatomical_site-END> of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
None	) . See Chan et al . 2005 for additional information about boost doses . 2.10 Gy fractions x 25 fractions over 5 weeks , given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : <RT_DOSE-START> 54 Gy <RT_DOSE-END> ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose :
DOSE-SITE	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
DOSE-SITE	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> areas at high risk <Anatomical_site-END> for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
DOSE-SITE	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had <Anatomical_site-START> inadequate resection margins <Anatomical_site-END> of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
DOSE-SITE	, given during cycle 1 of chemotherapy ( total dose : 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 6 fractions ( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions (
DOSE-SITE	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
DOSE-SITE	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> areas at high risk <Anatomical_site-END> for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
DOSE-SITE	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had <Anatomical_site-START> inadequate resection margins <Anatomical_site-END> of 2 Gy fractions x 6 fractions ( boost dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
DOSE-SITE	: 52.5 Gy ) 2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 <RT_DOSE-START> 12 Gy ) <RT_DOSE-END> 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to <Anatomical_site-START> areas at high risk <Anatomical_site-END> for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had <Anatomical_site-START> inadequate resection margins <Anatomical_site-END> of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	2 Gy fractions x 27 fractions ( total dose : 54 Gy ) , given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 Gy ) <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions
None	, given 5 times per week , with <Anatomical_site-START> boost <Anatomical_site-END> to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to <Anatomical_site-START> areas at high risk <Anatomical_site-END> for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had <Anatomical_site-START> inadequate resection margins <Anatomical_site-END> of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	, given 5 times per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : <RT_DOSE-START> 24 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions
None	per week , with <Anatomical_site-START> boost <Anatomical_site-END> to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to <Anatomical_site-START> areas at high risk <Anatomical_site-END> for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had <Anatomical_site-START> inadequate resection margins <Anatomical_site-END> of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	per week , with boost to areas at high risk for malignant dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose :
None	dissemination or that had <Anatomical_site-START> inadequate resection margins <Anatomical_site-END> of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	dissemination or that had inadequate resection margins of 2 Gy fractions x 6 fractions ( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2.00 Gy x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy
None	had <Anatomical_site-START> inadequate resection margins <Anatomical_site-END> of 2 Gy fractions x 6 fractions ( boost dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	had inadequate resection margins of 2 Gy fractions x 6 fractions ( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> x 34 to 35 fractions ( total dose of 68 to 70 Gy ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20
None	( <Anatomical_site-START> boost <Anatomical_site-END> dose : 12 Gy ) 1.5 Gy fractions given twice per day x 16 fractions ( total dose : 24 Gy ) 1.8 Gy fractions x 25 fractions , for a total dose of 45 Gy 2.00 Gy x 34 to 35 fractions ( total dose of 68 to <RT_DOSE-START> 68 to 70 Gy <RT_DOSE-END> ) 1.8 Gy x 25 fractions ( total dose : 45 Gy ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 6 times per week 2.25 Gy fractions x 20 fractions ( total dose of 45 Gy ) 2 Gy fractions x
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed
None	x 15 fractions , for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : <RT_DOSE-START> 66-70 Gy <RT_DOSE-END> ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END>
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy +
None	for a total dose of 40.05 Gy 1.8 Gy for 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy +
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	dose of 59.4 Gy ) 2 Gy fractions x 30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of <RT_DOSE-START> 36 to 39.6 Gy <RT_DOSE-END> , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	30 fractions , for a total dose of 60 Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	Gy 2.0 Gy fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the
None	fractions given 5 times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed
None	times per week ( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END>
DOSE-SITE	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
DOSE-SITE	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy
None	( total dose : 66-70 Gy ) 1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to
None	1.8 Gy fractions x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed <RT_DOSE-START> 50 Gy <RT_DOSE-END> + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
DOSE-SITE	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed
None	x 20 to 22 fractions , for an initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + <RT_DOSE-START> 20 Gy <RT_DOSE-END> boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END>
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x
None	initial total dose of 36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	36 to 39.6 Gy , started on day 8 1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions
None	1.80 Gy x 28 fractions , total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	, total dose of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	of 50.4 Gy to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
DOSE-SITE	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
DOSE-SITE	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	to 36 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 9 Gy <RT_DOSE-END> boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial
None	Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then
None	Gy boost to the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then
None	the <Anatomical_site-START> tumor bed <Anatomical_site-END> 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional
None	the tumor bed 50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional
None	50 Gy + 20 Gy <Anatomical_site-START> boost <Anatomical_site-END> ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
DOSE-SITE	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
DOSE-SITE	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate
None	50 Gy + 20 Gy boost ( total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END>
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65
None	total dose minimum of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to 70 Gy
None	of 70 Gy ) 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
DOSE-SITE	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	x 33 fractions ( total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then <RT_DOSE-START> 18 Gy <RT_DOSE-END> boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
DOSE-SITE	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	total dose : 66 Gy ) to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
DOSE-SITE	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to 40 Gy in 1.80-Gy fractions plus 9 Gy boost to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) ,
None	to the <Anatomical_site-START> tumor bed <Anatomical_site-END> to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
DOSE-SITE	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	to the tumor bed to 30 Gy in 1.80-Gy fractions plus 10 Gy boost to the tumor bed 45 Gy in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial <RT_DOSE-START> 44 to 46 Gy <RT_DOSE-END> to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy )
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
DOSE-SITE	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
DOSE-SITE	in 1.80 Gy fractions x 25 fractions , then 18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to <RT_DOSE-START> 65 to 70 Gy <RT_DOSE-END> in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy
None	18 Gy <Anatomical_site-START> boost <Anatomical_site-END> in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
DOSE-SITE	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
DOSE-SITE	18 Gy boost in 2.00 Gy fractions x 9 fractions 1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to <RT_DOSE-START> 60 to 65 Gy <RT_DOSE-END> total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	1.8 to 2 Gy per fraction , with an initial 44 to 46 Gy to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single
None	to 46 Gy to the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up
None	to 46 Gy to the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up
None	the <Anatomical_site-START> pelvis <Anatomical_site-END> , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions
None	the pelvis , then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions
None	then an additional <Anatomical_site-START> boost <Anatomical_site-END> to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the <Anatomical_site-START> prostate <Anatomical_site-END> that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target bone lesion for up to three bone lesions per patient ,
None	then an additional boost to the prostate that resulted in a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions per patient ,
None	a total dose of 65 to 70 Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose
None	Gy in definitive radiation patients ; 60 to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy
None	to 65 Gy total dose for post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions <RT_DOSE-START> 36 Gy <RT_DOSE-END> in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total
None	post-prostatectomy patients 58 to 66 Gy ) , given 5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions given focally at a single dose of 8 Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions (
DOSE-SITE	5 days per week 45 Gy ) 36 Gy in 2.00 Gy fractions , 5 days per week at 50.4 Gy in 28 fractions . was 36 Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to
None	Gy in 15 daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4
None	daily fractions 36 Gy in daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to <RT_DOSE-START> 10 to 12 Gy <RT_DOSE-END> total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given
None	daily fractions 1.80-Gy fractions given focally at a single dose of 8 Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total <RT_DOSE-START> 1200 cGy <RT_DOSE-END> in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary
None	Gy per target <Anatomical_site-START> bone lesion <Anatomical_site-END> for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of <Anatomical_site-START> primary bulky disease <Anatomical_site-END> ; 30 to 40 Gy to primary extranodal disease at physician discretion to
None	Gy per target bone lesion for up to three bone lesions per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) <RT_DOSE-START> 45 to 50.4 Gy <RT_DOSE-END> total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of <Anatomical_site-START> primary bulky disease <Anatomical_site-END> ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to primary tumor ( 70 to 74 Gy ) .
None	per patient , given 24 to 48 h before the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to <Anatomical_site-START> primary tumor <Anatomical_site-END> ( 70 to 74 Gy ) .
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of <Anatomical_site-START> primary bulky disease <Anatomical_site-END> ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
None	the first ipilimumab dose with a total dose of 60 Gy 10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to <Anatomical_site-START> primary tumor <Anatomical_site-END> ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total
DOSE-SITE	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of <Anatomical_site-START> primary bulky disease <Anatomical_site-END> ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
DOSE-SITE	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to <Anatomical_site-START> primary tumor <Anatomical_site-END> ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for
None	10 to 12 Gy total 1200 cGy in fractions ( pulmonary dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is 50 Gy for N0 disease ; 66 Gy for
DOSE-SITE	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of <Anatomical_site-START> primary bulky disease <Anatomical_site-END> ; 30 to <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
DOSE-SITE	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to <Anatomical_site-START> primary tumor <Anatomical_site-END> ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70
None	dosage was limited to 800 cGy ) 45 to 50.4 Gy total in 25 to 28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; <RT_DOSE-START> 30 to 40 Gy <RT_DOSE-END> to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; 70
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of <Anatomical_site-START> primary bulky disease <Anatomical_site-END> ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to primary tumor ( 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
DOSE-SITE	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to <Anatomical_site-START> primary tumor <Anatomical_site-END> ( 70 to <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . 60 Gy to the tumor bulk ,
None	28 fractions 45 Gy total in 25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( <RT_DOSE-START> 70 to 74 Gy <RT_DOSE-END> ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> ,
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of <Anatomical_site-START> primary bulky disease <Anatomical_site-END> ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to <Anatomical_site-START> primary tumor <Anatomical_site-END> ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> , with the tumor-bearing compartment receiving
None	25 fractions total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . <RT_DOSE-START> 64 Gy <RT_DOSE-END> 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the <Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of <Anatomical_site-START> primary bulky disease <Anatomical_site-END> ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to <Anatomical_site-START> primary tumor <Anatomical_site-END> ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> , with the tumor-bearing compartment receiving at least 44.8
None	total of 50 Gy given in 25 fractions with cycles 3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy <RT_DOSE-START> 54 Gy <RT_DOSE-END> Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the <Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving at least 44.8
None	3 and 4 30 to 40 Gy given to sites of <Anatomical_site-START> primary bulky disease <Anatomical_site-END> ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to <Anatomical_site-START> primary tumor <Anatomical_site-END> ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
DOSE-SITE	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	3 and 4 30 to 40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is <RT_DOSE-START> 50 Gy <RT_DOSE-END> for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the <Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving at least 44.8 Gy 24 Gy total given in 10 fractions from
None	40 Gy given to sites of <Anatomical_site-START> primary bulky disease <Anatomical_site-END> ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to <Anatomical_site-START> primary tumor <Anatomical_site-END> ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
DOSE-SITE	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	40 Gy given to sites of primary bulky disease ; 30 to 40 Gy to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; <RT_DOSE-START> 66 Gy <RT_DOSE-END> for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the <Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30
None	to <Anatomical_site-START> primary extranodal disease <Anatomical_site-END> at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to <Anatomical_site-START> primary tumor <Anatomical_site-END> ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
DOSE-SITE	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the <Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy .
None	to primary extranodal disease at physician discretion to primary tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; <RT_DOSE-START> 70 Gy <RT_DOSE-END> for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> of 64 to 66 Gy .
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
DOSE-SITE	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the <Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	tumor ( 70 to 74 Gy ) . 64 Gy 54 Gy Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . <RT_DOSE-START> 60 Gy <RT_DOSE-END> to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> of 64 to 66 Gy . No further details given about fractionation , schedule , or
None	Minimum total dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
DOSE-SITE	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the <Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	Minimum total dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to
None	dose to <Anatomical_site-START> neck nodes <Anatomical_site-END> is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the <Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	dose to neck nodes is 50 Gy for N0 disease ; 66 Gy for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> total given in 10 fractions from days 1 to 12 30 Gy total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy
None	for <Anatomical_site-START> nodes less than or equal to 2 cm <Anatomical_site-END> in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the <Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	for nodes less than or equal to 2 cm in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 <RT_DOSE-START> 30 Gy <RT_DOSE-END> total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy )
None	in size ; 70 Gy for <Anatomical_site-START> nodes greater than 2 cm <Anatomical_site-END> . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the <Anatomical_site-START> tumor bulk <Anatomical_site-END> , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the <Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
DOSE-SITE	in size ; 70 Gy for nodes greater than 2 cm . 60 Gy to the tumor bulk , with the tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> of 64 to <RT_DOSE-START> 64 to 66 Gy <RT_DOSE-END> . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with
None	<Anatomical_site-START> tumor-bearing compartment <Anatomical_site-END> receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the bladder of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
None	tumor-bearing compartment receiving at least 44.8 Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . <RT_DOSE-START> 40 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to
None	Gy 24 Gy total given in 10 fractions from days 1 to 12 30 Gy total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.2 Gy twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per
None	given in 10 fractions from days 1 to 12 30 Gy total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> twice per day fractions ( total dose : 69.6 Gy ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8
None	30 Gy total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> of 64 to 66 Gy . No further details given about fractionation , schedule , or dose to lymph nodes . 40 Gy in daily fractions of 1.80 to 2.00 Gy 1.2 Gy twice per day fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) 2 Gy fractions given 5 days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2
None	days per week , with total bladder dose of 60 Gy . Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 50.4 Gy in
None	Total dose to regional lymph nodes 60 Gy 68 to 72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not
None	72 Gy at 180 to 200 cGy per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of <RT_DOSE-START> 8 Gy <RT_DOSE-END> , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to
None	per day 64.8 Gy in 36 daily fractions of 1.80 Gy 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> fractions , to start within 24 hours of the start of chemotherapy to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for
DOSE-SITE	66 Gy ) , given 5 days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4
None	days per week in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2
None	in 2 Gy fractions once per day x 4 = total dose of 8 Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 50.4 Gy in 28 fractions 2 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a
None	Gy , without lung shielding 1.8 to 2.0 Gy fractions , to start within 24 hours of the start of chemotherapy to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in
None	50.4 Gy in 28 fractions 2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of <RT_DOSE-START> 46.0 to 50.4 Gy <RT_DOSE-END> 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week .
None	2 Gy 18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy <RT_DOSE-START> 45 Gy <RT_DOSE-END> 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions
None	18 Gy ( details not provided ) given during cycles 2 to 4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy <RT_DOSE-START> 2 Gy <RT_DOSE-END> at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose
None	4 : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 <RT_DOSE-START> 60 Gy <RT_DOSE-END> , details not available in abstract to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week
DOSE-SITE	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy
None	total of 23 to 28 fractions over 5 to 6 weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to 50 Gy
DOSE-SITE	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	weeks and a total dose of 46.0 to 50.4 Gy 45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : <RT_DOSE-START> 40 Gy <RT_DOSE-END> ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to 50 Gy 2.0 Gy fractions once per day ,
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
None	45 Gy 2 Gy at a rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . <RT_DOSE-START> 1.20 Gy <RT_DOSE-END> fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy )
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the <Anatomical_site-START> primary tumor <Anatomical_site-END> , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
None	rate of 0.07 Gy / min on day 0 60 Gy , details not available in abstract to the primary tumor , 1.8 to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : <RT_DOSE-START> 69.6 Gy <RT_DOSE-END> ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily
DOSE-SITE	to 2 Gy fractions ( median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to <RT_DOSE-START> 40 to 50 Gy <RT_DOSE-END> 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions
None	median total dose : 40 Gy ) , given 5 times per week . 1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to 50 Gy <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage
None	1.20 Gy fractions ( total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy
None	total dose : 69.6 Gy ) , given twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) <RT_DOSE-START> 46 to 50 Gy <RT_DOSE-END> in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	twice per day for 5 days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of <RT_DOSE-START> 1.80 to 2.00 Gy <RT_DOSE-END> 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details .
None	days per week , starting on cycle 1 day 1 to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	days per week , starting on cycle 1 day 1 to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250
None	to the <Anatomical_site-START> pelvis <Anatomical_site-END> , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	to the pelvis , 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy
None	, 40 to 50 Gy 2.0 Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy <RT_DOSE-START> 66 Gy <RT_DOSE-END> in 33 daily fractions of 2 Gy 25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated
None	Gy fractions once per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of <RT_DOSE-START> 2 Gy <RT_DOSE-END> 25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5
DOSE-SITE	per day , 5 times per week ( total dose : 70 Gy ) 46 to 50 Gy in daily fractions of 1.80 to 2.00 Gy 1.8 Gy fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy <RT_DOSE-START> 25 to 30 Gy <RT_DOSE-END> to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day
None	fractions x 25 fractions for a total dose of 45 Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in <RT_DOSE-START> 250 cGy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose :
None	Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and
None	Gy 66 Gy in 33 daily fractions of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and
None	of 2 Gy 25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose
None	of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume . The total dose
None	of 2 Gy 25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose <RT_DOSE-START> 70.6 Gy <RT_DOSE-END> 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> . The total dose
None	25 to 30 Gy to the <Anatomical_site-START> contralateral testis <Anatomical_site-END> . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole
DOSE-SITE	25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume . The total dose to the whole
DOSE-SITE	25 to 30 Gy to the contralateral testis . For patients with stage II disease , involved-field radiation therapy was added ; see paper for details . in 250 cGy fractions x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> . The total dose to the whole
DOSE-SITE	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
DOSE-SITE	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
None	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
None	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per
None	x 10 fractions ( total dose : 25 Gy ) hyperfractionated to total dose 70.6 Gy 2.5 Gy fractions twice per day , with at least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : <RT_DOSE-START> 20 Gy <RT_DOSE-END> ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> was 24 Gy in 8 fractions . in 3 Gy fractions once per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
DOSE-SITE	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
DOSE-SITE	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
None	least 4 hours between fractions , x 8 fractions , given on days 1 , 3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was <RT_DOSE-START> 44 Gy <RT_DOSE-END> in 16 fractions ; the total dose to the <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
DOSE-SITE	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 ,
None	3 , 15 , 17 ( total consolidation dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was <RT_DOSE-START> 24 Gy <RT_DOSE-END> in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 ,
None	dose : 20 Gy ) , administered to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 , then 2 Gy per day to the bladder
None	dose : 20 Gy ) , administered to the whole bladder and bladder tumor volume . The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in <RT_DOSE-START> 3 Gy <RT_DOSE-END> fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the <Anatomical_site-START> bladder <Anatomical_site-END>
None	The total dose to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then 2 Gy per day to the bladder tumor on days
None	The total dose to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of <RT_DOSE-START> 12 Gy <RT_DOSE-END> 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days
None	to the whole <Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20
None	to the whole bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy <RT_DOSE-START> 20 Gy <RT_DOSE-END> 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20
None	<Anatomical_site-START> bladder <Anatomical_site-END> and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy
None	bladder and bladder tumor volume was 44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy <RT_DOSE-START> 40 Gy <RT_DOSE-END> in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20 30 Gy
None	44 Gy in 16 fractions ; the total dose to the <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8
None	44 Gy in 16 fractions ; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20 30 Gy ( see note ) with 1.8
None	; the total dose to the <Anatomical_site-START> pelvic lymph nodes <Anatomical_site-END> was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
DOSE-SITE	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	; the total dose to the pelvic lymph nodes was 24 Gy in 8 fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
DOSE-SITE	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	fractions . in 3 Gy fractions once per day on days - 6 to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder on days 11 to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
DOSE-SITE	to - 3 = total dose of 12 Gy 20 Gy 40 Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then <RT_DOSE-START> 2 Gy <RT_DOSE-END> per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to
None	Gy in 20 fractions of 2.00 Gy per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 <RT_DOSE-START> 30 Gy <RT_DOSE-END> ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to
None	per fraction 2 Gy per day to the <Anatomical_site-START> pelvis <Anatomical_site-END> on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20 30 Gy ( see note ) with 1.8 to <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites ,
None	per fraction 2 Gy per day to the pelvis on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with <RT_DOSE-START> 1.8 to 2 Gy <RT_DOSE-END> fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> ,
None	on days 1 to 10 , then 2 Gy per day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x
None	on days 1 to 10 , then 2 Gy per day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x
None	day to the <Anatomical_site-START> bladder <Anatomical_site-END> on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	day to the bladder on days 11 to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for
None	to 14 , then 2 Gy per day to the <Anatomical_site-START> bladder tumor <Anatomical_site-END> on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
None	to 14 , then 2 Gy per day to the bladder tumor on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to
DOSE-SITE	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	on days 15 to 20 30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week <RT_DOSE-START> 40 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
DOSE-SITE	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	30 Gy ( see note ) with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , <RT_DOSE-START> 30.6 Gy <RT_DOSE-END> to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> <RT_DOSE-START> 36 Gy <RT_DOSE-END> to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
DOSE-SITE	with 1.8 to 2 Gy fractions for a total dose of 60 Gy to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites <RT_DOSE-START> 36 Gy <RT_DOSE-END> to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	to 50.4 Gy in 28 fractions 2 Gy fractions ( total dose : 58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction
None	58 to 66 Gy ) , given 5 times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8
None	58 to 66 Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of <RT_DOSE-START> 60 Gy <RT_DOSE-END> 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is 64.8
None	Gy ) , given 5 times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to
None	Gy ) , given 5 times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy <RT_DOSE-START> 24 to 36 Gy <RT_DOSE-END> 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is 64.8 Gy ; total dose to
None	times per week 40 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is 64.8 Gy ; total dose to lymph nodes is
None	times per week 40 Gy to involved sites , 30.6 Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy <RT_DOSE-START> 24 Gy <RT_DOSE-END> 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to <Anatomical_site-START> lymph nodes <Anatomical_site-END> is
None	Gy to <Anatomical_site-START> uninvolved sites <Anatomical_site-END> 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	Gy to uninvolved sites 36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) <RT_DOSE-START> 40 to 44 Gy <RT_DOSE-END> 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to <Anatomical_site-START> lymph nodes <Anatomical_site-END> is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy
None	36 Gy to <Anatomical_site-START> involved sites <Anatomical_site-END> , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	36 Gy to involved sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy <RT_DOSE-START> 21 Gy <RT_DOSE-END> in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to <Anatomical_site-START> lymph nodes <Anatomical_site-END> is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	sites , 30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of <RT_DOSE-START> 1.50 to 1.75 Gy <RT_DOSE-END> per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to <Anatomical_site-START> lymph nodes <Anatomical_site-END> is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
DOSE-SITE	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is <RT_DOSE-START> 64.8 Gy <RT_DOSE-END> ; total dose to <Anatomical_site-START> lymph nodes <Anatomical_site-END> is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is 64.8 Gy ; total dose to lymph nodes is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
DOSE-SITE	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to <Anatomical_site-START> lymph nodes <Anatomical_site-END> is <RT_DOSE-START> 45.6 Gy <RT_DOSE-END> . 20 Gy in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to <Anatomical_site-START> lymph nodes <Anatomical_site-END> is 45.6 Gy . <RT_DOSE-START> 20 Gy <RT_DOSE-END> in 5 fractions 54.4 Gy for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to <Anatomical_site-START> lymph nodes <Anatomical_site-END> is 45.6 Gy . 20 Gy in 5 fractions <RT_DOSE-START> 54.4 Gy <RT_DOSE-END> for a total dose of 61.2 Gy
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the <Anatomical_site-START> bladder <Anatomical_site-END> is 64.8 Gy ; total dose to lymph nodes is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
None	30.6 Gy to uninvolved sites 30 x 2.00 Gy fractions , five days per week , for a total dose of 60 Gy 24 to 36 Gy 24 Gy 30 Gy (+ 6 Gy boost ) 40 to 44 Gy 21 Gy in 12 to 14 fractions of 1.50 to 1.75 Gy per fraction After induction radiation therapy and consolidation radiation therapy , total dose to the bladder is 64.8 Gy ; total dose to <Anatomical_site-START> lymph nodes <Anatomical_site-END> is 45.6 Gy . 20 Gy in 5 fractions 54.4 Gy for a total dose of <RT_DOSE-START> 61.2 Gy <RT_DOSE-END>
